Other pleural conditions

J10_PLEUROTH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J94 Hospital discharge: ICD-9 — 511 Hospital discharge: ICD-8 — 511 Hospital discharge: excluded ICD-9 — 5111 Hospital discharge: excluded ICD-8 — 511[1-2] Cause of death: ICD-10 — J94 Cause of death: ICD-9 — 511 Cause of death: ICD-8 — 511 Cause of death: excluded ICD-9 — 5111 Cause of death: excluded ICD-8 — 511[1-2] 2 out of 7 registries used, show all original rules.	5095
4. Check minimum number of events None	5095
5. Include endpoints None	5095
6. Filter based on genotype QC (FinnGen only)	4462

Control definitions (FinnGen only)

Control exclude: J10_PLEURA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J90-J94
Name in latin: Aliae morbositates pleurae

NAME	J10_PLEUROTH
CONTROL_EXCLUDE	J10_PLEURA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J94
HD_ICD_9	511
HD_ICD_8	511
HD_ICD_10_EXCL
HD_ICD_9_EXCL	5111
HD_ICD_8_EXCL	511[1-2]
COD_MAINONLY
COD_ICD_10	J94
COD_ICD_9	511
COD_ICD_8	511
COD_ICD_10_EXCL
COD_ICD_9_EXCL	5111
COD_ICD_8_EXCL	511[1-2]
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other pleural conditions based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	35764	13302	21866
Only index persons	25352	10084	15268
Unadjusted period prevalence (%)
Whole population	0.53	0.38	0.61
Only index persons	0.50	0.37	0.58
Median age at first event (years)
Whole population	67.99	70.47	66.53
Only index persons	68.38	70.79	66.78

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4462	1538	2924
Unadjusted period prevalence (%)	1.07	0.55	1.34
Median age at first event (years)	68.65	68.81	68.57

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4608: Matched controls
46080

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R06.0

ICD-10 Finland

Dyspnoea

3.2

322.2

2018

8922

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.4

320.7

3159

18117

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.4

310.9

1523

5786

TGA30

NOMESCO Finland

Thoracocentesis

149.1

307.7

345

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

65.7

307.7

183

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

42.3

307.7

705

196

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

27.2

307.7

1128

543

5119X

ICD-9 Finland

Pleurisy, Unspecified pleural effusion

+∞

307.7

382

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

40.7

307.7

547

152

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

232.3

307.7

324

GD1AD

NOMESCO Finland

Thorax CT examination

6.2

307.7

772

1450

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1337.9

307.7

1582

J94.8

ICD-10 Finland

Other specified pleural conditions

6294.6

307.7

2767

UGC12

NOMESCO Finland

Flexible bronchoscopy

5.0

307.7

854

2001

J94.9

ICD-10 Finland

Pleural condition, unspecified

4171.8

307.7

730

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

19.7

307.7

620

360

J94.2

ICD-10 Finland

Haemothorax

673.2

307.7

429

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.9

303.6

1112

3488

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

6.0

297.2

574

1075

C03CA01

ATC

furosemide; systemic

3.0

288.4

2634

14158

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

55.9

286.7

162

C45.0

ICD-10 Finland

Mesothelioma of pleura

78.8

271.6

145

Z51.5

ICD-10 Finland

Palliative care

3.8

261.8

968

3031

J86.9

ICD-10 Finland

Pyothorax without fistula

17.6

260.0

214

127

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.7

254.3

961

3049

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.8

252.0

2104

10567

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

+∞

246.1

234

JN4AD

NOMESCO Finland

Body CT examination

3.5

245.6

1036

3525

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

14.0

234.8

219

164

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

42.1

231.3

139

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.3

228.1

666

1753

I50.9

ICD-10 Finland

Heart failure, unspecified

2.8

199.2

1406

6331

N02AA05

ATC

oxycodone; systemic

2.7

198.6

1489

6910

J96.1

ICD-10 Finland

Chronic respiratory failure

962.2

190.0

185

GAC00

NOMESCO Finland

Biopsy of pleura

333.5

188.8

190

JN4BD

NOMESCO Finland

Extensive body CT

3.2

181.9

850

3036

A03FA01

ATC

metoclopramide; systemic, rectal

2.7

181.6

1365

6300

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

4.8

172.2

412

921

H02AB02

ATC

dexamethasone; systemic

3.1

169.6

822

2991

H02AB06

ATC

prednisolone; systemic

2.3

158.7

2556

16298

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.4

153.6

407

985

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

22.5

152.7

112

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.7

149.7

950

3982

130

Kela drug reimbursment

Malignant tumour

3.0

148.4

769

2892

A04AA01

ATC

ondansetron; systemic, rectal

3.4

146.1

590

1914

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.2

142.2

406

1039

GAC01

NOMESCO Finland

Endoscopic biopsy of pleura

240.6

136.8

140

R18

ICD-10 Finland

Ascites

6.1

136.6

244

418

J01MA14

ATC

moxifloxacin; systemic

3.1

136.2

637

2253

I50.0

ICD-10 Finland

Congestive heart failure

2.8

129.6

762

3052

51101

ICD-8 Finland

Pleurisy, Adhaesiones pleurae

+∞

127.7

122

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.7

127.0

834

3532

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

51.5

123.5

J98.1

ICD-10 Finland

Pulmonary collapse

68.0

122.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

120.4

871

3858

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

6.4

117.4

198

320

J01MA12

ATC

levofloxacin; systemic

2.3

115.8

1198

6205

J92.9

ICD-10 Finland

Pleural plaque without asbestos

140.4

115.7

123

GAA31

NOMESCO Finland

Thoracoscopy

26.8

115.1

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

6.0

114.8

206

354

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

113.8

1316

7122

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

113.6

1381

7622

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.8

113.6

267

585

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

3.9

105.2

324

872

WX892

NOMESCO Finland

Monitored bed care

2.9

104.5

559

2116

C03DA01

ATC

spironolactone; oral

2.4

103.9

893

4254

L01CA04

ATC

vinorelbine; systemic

9.4

97.7

117

127

TGC00

NOMESCO Finland

Bronchial lavation

5.0

95.5

213

446

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.0

94.8

452

1603

N02AA01

ATC

morphine; systemic, rectal

4.8

94.1

218

471

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

6.5

93.1

155

247

R02

ICPC

Shortness of breath/dyspnoea

2.3

89.5

811

3930

ZX120

NOMESCO Finland

Intravenous

2.6

87.8

586

2473

WF049

NOMESCO Finland

Radiotherapy of metastasis

3.6

87.5

305

892

A04AA02

ATC

granisetron; systemic, transdermal

3.0

86.6

409

1440

J96.0

ICD-10 Finland

Acute respiratory failure

106.6

86.2

J94.0

ICD-10 Finland

Chylous effusion

+∞

85.7

9050/3-C38.4

ICD-O-3

Mesothelioma, malignant of pleura, NOS

40.4

85.5

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

9.7

83.8

103

L03AA13

ATC

pegfilgrastim; parenteral

3.6

82.9

288

840

51109

ICD-8 Finland

Pleurisy, Sicca NUD

+∞

82.5

R03BB04

ATC

tiotropium bromide; inhalant

2.4

82.3

676

3132

WW500

NOMESCO Finland

Blood transfusion

3.4

81.6

310

958

1240

FHL

Bronchoscopy

6.1

80.6

141

236

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.9

80.4

410

1505

C56

ICD-10 Finland

Malignant neoplasm of ovary

13.0

80.3

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.0

79.9

369

1282

R50.9

ICD-10 Finland

Fever, unspecified

2.1

79.8

858

4436

TK800

NOMESCO Finland

Hemodialysis

4.6

76.9

187

420

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

76.8

1354

8320

B01AB05

ATC

enoxaparin; parenteral

1.8

75.8

1624

10596

J94.1

ICD-10 Finland

Fibrothorax

729.8

73.4

J93.8

ICD-10 Finland

Other pneumothorax

729.8

73.4

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

5.5

73.2

143

266

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.6

73.1

118

182

S27.1

ICD-10 Finland

Traumatic haemothorax

8.8

72.4

105

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

71.3

1130

6681

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

69.3

1539

10088

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.0

68.8

326

1147

128

Kela drug reimbursment

Cancers of female genital organs

5.6

68.8

131

238

B03XA02

ATC

darbepoetin alfa; parenteral

4.1

68.6

193

485

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.9

68.5

354

1306

R03AC02

ATC

salbutamol; inhalant

1.7

68.5

2275

16687

A02BC02

ATC

pantoprazole; systemic

1.8

68.1

3156

25360

B01AA03

ATC

warfarin; systemic

1.8

67.9

1365

8675

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

9.7

66.6

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

66.0

1646

11122

1501

Kela drug reimbursment

Palbociclib

11.7

65.4

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.2

65.1

621

3044

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

6.2

63.2

109

180

C07AB07

ATC

bisoprolol; oral

1.7

62.9

2640

20424

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

4.3

62.9

168

406

394

Kela drug reimbursment

Palbociclib

11.8

61.9

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

+∞

61.6

J93.9

ICD-10 Finland

Pneumothorax, unspecified

317.1

61.5

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

4.0

61.4

178

457

B01AB10

ATC

tinzaparin; parenteral

2.2

61.3

589

2892

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

61.0

1674

11553

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

60.9

1511

10141

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.1

60.5

171

431

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

6.5

58.7

150

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

13.6

57.9

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

57.8

2125

15758

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

575.3

57.8

ZXD05

NOMESCO Finland

Urgent procedure

1.7

57.7

1440

9652

R84

ICPC

Malignant neoplasm bronchus/lung

9.8

57.2

192

Kela drug reimbursment

Fulvestrant

10.5

57.0

9052/3-C38.4

ICD-O-3

Epithelioid mesothelioma, malignant of pleura, NOS

565.0

56.7

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

56.7

488

2287

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.5

56.2

195

567

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

56.2

1197

7665

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

56.0

521

2520

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.1

55.8

238

787

A06AH03

ATC

naloxegol; oral

4.9

55.4

124

260

JN4CD

NOMESCO Finland

Very extensive body CT

3.0

55.0

255

885

XG410

NOMESCO Finland

Flow-volume spirometry

3.1

54.8

233

769

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

16.6

54.8

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

54.3

336

1356

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.2

54.2

225

732

WX872

NOMESCO Finland

Intensive care

2.6

53.8

334

1350

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.5

53.7

188

550

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

53.4

849

4968

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

6.0

53.3

162

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

52.9

629

3336

127

Kela drug reimbursment

Transplant complication

5.5

52.3

101

186

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

52.0

661

3588

N05CF01

ATC

zopiclone; oral

1.6

51.1

1607

11360

A04AA55

ATC

palonosetron, combinations; systemic

3.6

50.8

173

497

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.3

50.7

397

1785

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

5.4

50.4

185

L02BA03

ATC

fulvestrant; parenteral

8.2

50.4

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

49.8

691

3861

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.6

49.7

312

1267

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

49.6

904

5506

L03AA14

ATC

lipegfilgrastim; parenteral

4.7

49.2

115

250

S22.4

ICD-10 Finland

Multiple fractures of ribs

3.5

49.0

173

509

D38.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pleura

17.5

48.9

N02AX02

ATC

tramadol; systemic, rectal

1.6

48.3

2018

15211

WZC30

NOMESCO Finland

Teaching

1.8

48.3

802

4744

J01FF01

ATC

clindamycin; systemic

1.7

48.1

1204

8005

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

48.0

682

3837

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.6

47.8

115

256

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.1

47.6

206

687

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.6

47.0

161

L04AA06

ATC

mycophenolic acid; systemic

4.5

46.7

115

261

I50.1

ICD-10 Finland

Left ventricular failure

2.3

45.6

384

1778

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

3.7

45.0

148

415

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

8.8

44.9

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

3.9

44.8

136

361

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

3.3

44.3

172

537

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.1

43.9

120

295

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

43.9

179

576

L01EF01

ATC

palbociclib; oral

12.4

43.5

L03AA02

ATC

filgrastim; parenteral

3.1

42.8

181

595

M05BX04

ATC

denosumab; parenteral

2.3

42.8

364

1692

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.1

42.8

117

288

A11CC03

ATC

alfacalcidol; systemic

3.2

42.5

175

566

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

42.1

888

5608

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

41.9

318

1407

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

6.0

41.5

123

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

41.0

493

2614

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

8.7

40.5

N18.8

ICD-10 Finland

Other chronic renal failure

3.0

40.3

188

654

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

8.6

40.0

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.5

39.9

218

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

11.1

39.8

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.1

39.6

165

538

L01XE33

ATC

[U] palbociclib

11.9

39.4

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

39.4

547

3044

WF004

NOMESCO Finland

Palliative radiotherapy

3.2

38.8

159

513

C01AA05

ATC

digoxin; systemic

1.9

38.7

596

3425

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.8

38.6

125

R04.2

ICD-10 Finland

Haemoptysis

2.6

38.3

234

937

JAL30

NOMESCO Finland

Omentectomy

5.6

38.2

133

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

37.7

680

4098

R4190

NOMESCO Finland

Nutritional therapy

2.9

37.7

185

662

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.5

37.3

130

379

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

8.2

37.2

SPAT1062

SPAT

Lung clearance therapy

9.4

37.1

I50

ICD-10 Finland

Heart failure

2.5

36.7

243

1011

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

36.2

482

2642

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

4.2

36.0

232

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

35.9

690

4230

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

35.8

728

4532

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.7

35.6

197

751

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

5.3

35.5

135

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

35.4

239

1003

A12AA04

ATC

calcium carbonate; oral

3.6

35.2

116

326

SPAT1269

SPAT

Other puncture and/or drainage

6.7

34.8

SPAT1254

SPAT

Administration of medicine

1.7

34.7

759

4816

N03AX16

ATC

[U] pregabalin

1.6

34.7

989

6709

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

34.7

1267

9098

5118X

ICD-9 Finland

Pleurisy, Other specified forms of effusion, except tuberculous

+∞

34.4

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

4.0

34.4

249

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

9.6

34.1

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.8

34.0

178

659

J96.9

ICD-10 Finland

Respiratory failure, unspecified

42.3

34.0

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.1

34.0

238

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

13.4

33.9

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.9

33.9

152

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

8.8

33.7

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.1

33.5

144

478

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

33.4

793

5136

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.5

33.4

186

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

33.2

251

1108

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.1

33.1

348

1753

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.1

33.0

144

482

Z2446

NOMESCO Finland

Social worker

2.2

32.9

289

1358

AA1AD

NOMESCO Finland

CT of head and brain

1.5

32.9

1490

11170

A06AD11

ATC

lactulose; oral

1.6

32.9

875

5831

L02BG04

ATC

letrozole; oral

2.3

32.2

248

1103

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.3

32.2

248

1103

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

32.1

272

1260

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

31.8

826

5467

5861

FHL

Pleural biopsy or removal of local change

88.2

31.7

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

6.3

31.7

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

31.6

188

743

XG466

NOMESCO Finland

Sleep oxymetry

2.9

31.6

149

522

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.7

31.4

102

284

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.2

31.3

264

1221

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

31.2

392

2104

A46

ICD-10 Finland

Erysipelas

1.6

31.0

774

5069

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

4.2

30.8

198

L04AD02

ATC

tacrolimus; systemic

5.5

30.8

108

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.2

30.6

272

1284

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

30.3

325

1649

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.2

30.0

276

1321

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.6

29.9

270

J01DB01

ATC

cefalexin; oral

1.5

29.8

3441

30560

TJA10

NOMESCO Finland

Laparocentesis

9.5

29.7

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.1

29.7

R95

ICPC

Chron obstructive pulmonary disease

2.6

29.5

176

696

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

29.3

253

1180

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.1

29.3

282

1373

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.1

28.9

122

M04AA01

ATC

allopurinol; systemic

1.6

28.8

806

5417

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.5

28.7

192

802

P01BA02

ATC

hydroxychloroquine; oral

2.0

28.7

324

1674

N18.0

ICD-10 Finland

End-stage renal disease

3.9

28.6

218

SPAT1263

SPAT

Sampling

1.4

28.5

1713

13462

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

3.7

28.5

246

ZXE00

NOMESCO Finland

One hour or less

1.4

28.5

1589

12320

WX882

NOMESCO Finland

High dependency care

2.7

28.5

159

609

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

28.3

372

2024

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.2

28.3

256

1218

A79

ICPC

Malignancy NOS

3.2

28.2

114

365

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.9

28.2

132

460

A04AD12

ATC

aprepitant; systemic

3.5

27.8

269

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.0

27.8

126

432

TK810

NOMESCO Finland

Hemofiltration

5.6

27.5

115

Kela drug reimbursment

Breast cancer

2.0

27.5

297

1510

N02BE01

ATC

paracetamol; systemic, rectal

1.6

27.3

3843

35130

A28

ICPC

Limited function/disability NOS

1.5

27.3

1041

7483

R4110

NOMESCO Finland

Physiotherapy

1.5

27.1

1193

8825

L01BC06

ATC

capecitabine; oral

2.3

27.0

205

906

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.2

26.7

241

1145

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.0

26.5

119

406

137

Kela drug reimbursment

Uraemia requiring dialysis

4.5

26.3

140

SPAT1262

SPAT

Handing over of treatment supplies

1.5

26.3

831

5731

L02BA01

ATC

tamoxifen; oral

2.6

26.3

156

616

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

26.3

773

5247

L04AX01

ATC

azathioprine; systemic

2.5

26.3

170

700

Z94.0

ICD-10 Finland

Kidney transplant status

4.5

26.1

145

JN6AD

NOMESCO Finland

CT of torso and neck

3.1

25.8

106

343

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.1

25.8

238

1140

J01CA04

ATC

amoxicillin; systemic

1.4

25.8

3255

28889

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.1

25.7

106

344

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

3.4

25.6

274

Z57.2

ICD-10 Finland

Occupational exposure to dust

21.9

25.6

Z3231

NOMESCO Finland

Registered nurse

1.5

25.4

1198

8960

207

Kela drug reimbursment

Chronic arrhythmias

1.5

25.4

932

6634

V03AE02

ATC

sevelamer; oral

6.2

25.3

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

25.3

1398

10766

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

3.6

25.1

239

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

7.2

25.0

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

24.9

319

1720

V03AE01

ATC

polystyrene sulfonate; oral

3.2

24.9

101

325

GA2AT

NOMESCO Finland

Pleural biopsy with ultrasound guidance

32.2

24.6

C38.4

ICD-10 Finland

Malignant neoplasm: Pleura

32.2

24.6

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.8

24.4

120

430

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

24.3

240

1181

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

24.2

246

1223

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

23.9

289

1528

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.1

23.9

160

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

23.8

1728

13914

GAC10

NOMESCO Finland

Removal of foreign body from pleural cavity

241.2

23.7

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

23.6

234

1152

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.7

23.5

202

H02AB07

ATC

prednisone; oral

1.6

23.5

591

3860

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

4.1

23.4

158

SPAT1255

SPAT

Intravenous administration of medicine

1.9

23.4

331

1843

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.0

23.3

163

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

23.3

578

3762

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

3.4

22.9

239

K77

ICPC

Heart failure

2.4

22.9

160

682

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

2.2

22.9

203

957

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

22.9

471

2922

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.5

22.9

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

6.1

22.8

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

22.7

1505

11915

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

22.5

731

5057

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

6.8

22.5

Z49.2

ICD-10 Finland

Other dialysis

4.6

22.4

113

A07AA09

ATC

vancomycin; oral

3.2

22.4

273

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

22.3

309

1710

A10AB05

ATC

insulin aspart; parenteral

1.8

22.3

368

2148

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

22.2

202

963

QBC00

NOMESCO Finland

Removal of foreign body from skin of trunk or subcutaneous tissue

24.0

22.1

C01BD01

ATC

amiodarone; systemic

2.3

22.1

177

801

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.0

22.1

229

1147

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.0

22.1

322

5111B

ICD-9 Finland

Pleurisy, With effusion, with mention of a bacterial cause other than tuberculosis[PLEURITIS EXSUDATIVA ALIA DEFINITA]

+∞

21.9

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

21.8

195

923

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

3.6

21.7

204

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.4

21.6

151

644

GAC37

NOMESCO Finland

Endoscopic chemical pleurodesis

221.0

21.6

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

3.7

21.5

182

N05BA04

ATC

oxazepam; oral

1.4

21.5

1069

8037

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.8

21.4

107

388

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

5.7

21.1

J01AA02

ATC

doxycycline; systemic

1.4

21.1

3232

29030

TGD00

NOMESCO Finland

Needle biopsy of lung

5.8

21.0

B05DA

ATC

Isotonic solutions

4.5

21.0

115

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

21.0

447

2797

S27.0

ICD-10 Finland

Traumatic pneumothorax

4.2

20.9

132

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

3.4

20.9

224

R11

ICD-10 Finland

Nausea and vomiting

1.7

20.9

364

2157

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.9

20.8

255

1354

GAA97

NOMESCO Finland

Other thoracoscopic drainage procedures on pleura

37.4

20.8

R82

ICPC

Pleurisy/pleural effusion

37.4

20.8

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

20.7

132

540

TGA10

NOMESCO Finland

Needle biopsy of pleura

110.5

20.6

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

2.7

20.3

106

393

3AC01, ,

NOMESCO Finland

4.0

20.3

144

01220

ICD-8 Finland

Other respiratory tuberculosis, Pleurisy with effusion without mention of cause

8.4

20.1

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

2.4

20.1

133

554

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

16.1

20.1

WW200, ,

SPAT

0.7

20.1

661

9256

R03BB01

ATC

ipratropium bromide; inhalant

2.0

20.0

230

1195

R81

ICPC

Pneumonia

2.1

20.0

186

894

L04AA01

ATC

[U] ciclosporin

3.6

20.0

182

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

20.0

252

1352

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

23.5

19.9

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

19.8

513

7556

B03XA01

ATC

erythropoietin; parenteral

3.6

19.8

183

GAC36

NOMESCO Finland

Chemical pleurodesis

+∞

19.8

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

19.8

218

1117

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.1

19.7

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

3.5

19.7

193

Z3226

NOMESCO Finland

Physiotherapist

1.5

19.7

742

5280

GX2C5

NOMESCO Finland

Short-lasting oximetry

6.4

19.6

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.4

19.6

141

610

L04AX03

ATC

methotrexate; systemic

1.7

19.6

345

2050

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

5.2

19.5

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

19.5

180

864

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

19.4

278

1553

B05DB

ATC

Hypertonic solutions

4.5

19.4

106

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

19.3

1450

11639

J01FA06

ATC

roxithromycin; oral

1.4

19.2

1523

12323

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

7.9

19.1

R53

ICD-10 Finland

Malaise and fatigue

1.4

19.1

1054

8042

S22.3

ICD-10 Finland

Fracture of rib

1.7

19.1

345

2063

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.7

19.1

366

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.1

19.1

124

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

2.9

19.1

311

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

2.1

19.1

174

831

WX730

NOMESCO Finland

Conventional respirator

3.0

19.0

279

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

2.5

19.0

120

489

HAC20

NOMESCO Finland

Total mastectomy

2.3

19.0

145

644

B01AB04

ATC

dalteparin; parenteral

1.9

19.0

239

1282

AN1

Coronary angiography

1.5

18.9

614

4237

197

Kela drug reimbursment

Sunitinib

5.8

18.8

J01XX08

ATC

linezolid; systemic

4.5

18.7

101

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.7

18.6

382

2365

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

18.6

137

599

0120X

ICD-9 Finland

Other respiratory tuberculosis, Tuberculous pleurisy[TUBERCULOSIS PLEURAE, EPÄILTY]

100.5

18.6

TK820

NOMESCO Finland

Peritoneal dialysis

5.4

18.5

C50.99

ICD-10 Finland

Breast, unspecified

2.6

18.5

110

436

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.8

18.4

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

18.3

207

1071

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.0

18.2

276

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.9

18.1

138

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.0

18.1

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

18.0

1221

9627

XF404

NOMESCO Finland

Ambulatory ECG

1.6

18.0

412

2624

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

6.5

17.9

HA1AA

NOMESCO Finland

X-ray mammography

1.8

17.8

253

1410

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.3

17.8

105

GAC30

NOMESCO Finland

Artificial pneumothorax

+∞

17.7

51120

ICD-8 Finland

Pleurisy, Other specified forms of effusion, except tuberculous

+∞

17.7

J98.6

ICD-10 Finland

Disorders of diaphragm

66.9

17.7

GAC46

NOMESCO Finland

Partial decortication of pleura

20.1

17.7

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

3.6

17.6

159

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

17.5

1323

10593

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

17.5

717

5177

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.2

17.4

142

648

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

4.2

17.4

111

Z94.4

ICD-10 Finland

Liver transplant status

7.8

17.4

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

7.8

17.4

WPA13

NOMESCO Finland

Palliative consultation

5.1

17.4

WPB10

NOMESCO Finland

Making a convalescent care decision

5.1

17.4

1502

Kela drug reimbursment

Cabozantinib

7.1

17.4

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.2

17.3

210

JAH01

NOMESCO Finland

Laparoscopy

2.1

17.3

155

735

GAC47

NOMESCO Finland

Endoscopic partial decortication of pleura

20.9

17.3

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.6

17.2

380

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

4.0

17.2

125

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.4

17.2

181

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.8

17.2

275

1589

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

17.1

737

5369

R03BA05

ATC

fluticasone; inhalant

1.5

17.1

630

4455

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

16.0

17.0

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.0

16.9

239

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

16.9

438

2871

WX722

NOMESCO Finland

PEEP

1.9

16.9

204

1079

GAC96

NOMESCO Finland

Other operation on pleura

25.7

16.9

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

16.9

1207

9577

S97

ICPC

Chronic ulcer skin

1.7

16.8

329

2011

WX002

NOMESCO Finland

Sedation and analgesia

1.4

16.7

809

6018

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

16.6

386

2466

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

16.5

434

2853

K78

ICPC

Atrial fibrillation/flutter

1.6

16.5

456

3032

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

16.4

210

1132

A10AE04

ATC

insulin glargine; parenteral

1.6

16.4

445

2947

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

16.4

139

645

5862

FHL

Decortication (removal of visceral or parietal pleura)

23.1

16.4

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

16.4

132

600

X76

ICPC

Malignant neoplasm breast female

2.9

16.2

272

L02BG06

ATC

exemestane; oral

3.1

16.2

214

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

16.2

476

3211

3012

Kela drug reimbursment

Cabozantinib

6.8

16.1

C01DA14

ATC

isosorbide mononitrate; oral

1.4

16.1

974

7521

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

5.3

16.1

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.3

16.0

119

523

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.0

15.9

110

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

4.6

15.8

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

15.8

380

2446

L04AD01

ATC

ciclosporin; systemic

3.0

15.8

238

GDA10

NOMESCO Finland

Biopsy of lung

7.2

15.7

N19

ICD-10 Finland

Unspecified kidney failure

1.8

15.6

226

1267

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

85.4

15.6

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

5.6

15.5

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

15.5

610

4364

WW200

NOMESCO Finland

Immunization

2.4

15.5

110

474

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.0

15.4

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

15.4

194

1041

R03BA01

ATC

beclometasone; inhalant

1.5

15.4

526

3660

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

15.4

182

957

W19

ICD-10 Finland

Unspecified fall

1.5

15.4

432

2884

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.6

15.3

346

2193

E87.5

ICD-10 Finland

Hyperkalaemia

2.3

15.3

116

514

191

Kela drug reimbursment

Erlotinib

6.7

15.3

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2.2

15.2

129

599

WVA20

NOMESCO Finland

Medicine administration

2.2

15.2

125

574

R60.0

ICD-10 Finland

Localized oedema

1.5

15.1

575

4085

H02AB04

ATC

methylprednisolone; systemic

1.5

15.1

547

3850

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.4

15.0

101

425

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.7

15.0

301

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

15.0

216

1210

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.8

15.0

243

1410

A41.8

ICD-10 Finland

Other specified sepsis

2.3

15.0

112

494

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.5

14.8

373

R29

ICPC

Respiratory symptom/complaint other

1.7

14.8

247

1445

SPAT1056

SPAT

Pleural puncture

31.8

14.8

9051/3-C38.4

ICD-O-3

Fibrous mesothelioma, malignant of pleura, NOS

56.9

14.8

J01MA02

ATC

ciprofloxacin; systemic

1.3

14.8

1725

14596

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.7

14.8

293

1798

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.3

14.7

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4.9

14.7

R06AE07

ATC

cetirizine; oral

1.3

14.7

1445

11951

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

4.4

14.7

J98.4

ICD-10 Finland

Other disorders of lung

25.1

14.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

14.6

304

1887

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.3

14.6

115

518

R28

ICPC

Limited function/disability (R)

2.9

14.6

227

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.3

14.6

107

468

NK6AN

NOMESCO Finland

Total body bone isotope imaging

2.0

14.6

148

737

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

14.6

331

2102

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.1

14.5

131

624

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

14.5

543

3845

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.7

14.5

295

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

3.4

14.5

156

GX1K5

NOMESCO Finland

Diffusion capacity

4.5

14.5

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

3.0

14.4

202

ZX108

NOMESCO Finland

Inhalation

4.1

14.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

14.4

1460

12117

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.7

14.3

286

1757

L28

ICPC

Limited function/disability (L)

1.4

14.3

913

7093

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

5.5

14.3

UJF32

NOMESCO Finland

Coloscopy

1.3

14.3

1126

9028

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

14.3

319

2018

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.7

14.2

236

1380

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

14.2

397

2647

C09AA05

ATC

ramipril; oral

1.3

14.1

1251

10191

C07AB02

ATC

metoprolol; systemic

1.3

14.1

1027

8137

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.2

14.1

115

527

SPAT1216

SPAT

Assessment of functional ability

1.4

14.1

743

5598

N17.8

ICD-10 Finland

Other acute renal failure

2.6

14.0

294

196

Kela drug reimbursment

Paricalcitol and cinacalcet

4.9

14.0

N06AX11

ATC

mirtazapine; oral

1.3

14.0

1266

10338

ZX112

NOMESCO Finland

Subcutaneous

2.3

14.0

102

445

L01BA01

ATC

methotrexate; systemic

2.1

14.0

137

674

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

14.0

304

1910

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.0

13.9

201

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.3

13.9

155

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

13.9

640

4709

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

13.8

249

1488

WX721

NOMESCO Finland

Oxygen concentrator therapy

17.6

13.8

R03AC12

ATC

salmeterol; inhalant

1.8

13.7

203

1147

Z2221

NOMESCO Finland

Medical doctor

1.3

13.7

1021

8111

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

5.3

13.7

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.0

13.7

198

H3603, E103,

ICD-10 Finland

4.2

13.7

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

6.5

13.6

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

13.6

305

1930

1500

FHL

Thoracoscopy

75.4

13.6

5110A

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURITIS SICCA]

+∞

13.5

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

+∞

13.5

1BA04, ,

NOMESCO Finland

16.2

13.4

1510

Kela drug reimbursment

Niraparib

21.2

13.3

3009

Kela drug reimbursment

Niraparib

21.2

13.3

I97.0

ICD-10 Finland

Postcardiotomy syndrome

4.7

13.3

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.7

13.3

251

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

13.3

409

2784

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

3.0

13.3

191

SPAT1260

SPAT

Consultation of another employee

1.4

13.2

673

5036

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.1

13.2

126

614

N05CD07

ATC

temazepam; oral

1.4

13.1

571

4156

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

13.1

619

4572

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

4.9

13.1

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

12.2

13.1

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

3.7

13.1

108

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.5

13.0

X77

ICPC

Malignant neopl genital female other

5.9

13.0

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

13.0

353

2337

R09.1

ICD-10 Finland

Pleurisy

2.6

13.0

271

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

13.0

126

618

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

12.9

2608

23434

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

12.9

1661

14157

J43.9

ICD-10 Finland

Emphysema, unspecified

2.4

12.9

349

B01AF02

ATC

apixaban; oral

1.4

12.9

686

5169

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

12.9

886

6951

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

1.8

12.8

205

1185

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

4.7

12.8

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.4

12.8

357

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

5.8

12.7

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

2.9

12.7

196

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

4.3

12.6

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.0

12.6

135

686

NHQ40

NOMESCO Finland

Amputation of toe

2.3

12.6

440

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

12.6

499

6829

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

4.9

12.6

R06.2

ICD-10 Finland

Wheezing

1.9

12.6

159

855

GAC43

NOMESCO Finland

Total decortication of pleura

70.1

12.6

E0000UV, ,

ATC

1.3

12.6

1555

13183

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.6

12.5

288

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

3.9

12.5

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

12.5

851

6663

L01XE04

ATC

[U] sunitinib

6.2

12.5

J86.09

ICD-10 Finland

Pyothorax with fistula

24.4

12.4

A16.5

ICD-10 Finland

Tuberculous pleurisy, without mention of bacteriological or histological confirmation

130.4

12.4

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.5

12.4

295

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

12.4

1181

9685

R99

ICPC

Respiratory disease other

2.4

12.3

332

JAH00

NOMESCO Finland

Laparotomy

2.0

12.3

130

658

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

2.8

12.3

216

A10AE05

ATC

insulin detemir; parenteral

1.7

12.3

222

1329

M05BA04

ATC

alendronic acid; oral

1.5

12.3

363

2448

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.9

12.2

153

821

RS221, ,

NOMESCO Finland

2.8

12.2

206

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.8

12.1

171

953

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

2.1

12.1

111

533

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

4.1

12.0

SPAT1109

SPAT

Analgesia with portable analgesic pump

3.3

12.0

134

R77.0

ICD-10 Finland

Abnormality of albumin

11.0

12.0

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

12.0

144

762

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

2.9

12.0

197

R05

ICD-10 Finland

Cough

1.3

12.0

764

5920

A02BC05

ATC

esomeprazole; systemic

1.3

12.0

1520

12908

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.7

11.9

101

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

3.7

11.9

101

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.4

11.9

350

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

4.4

11.9

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4.8

11.9

J92

ICD-10 Finland

Pleural plaque

46.8

11.9

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.5

11.8

284

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

2.5

11.8

308

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.1

11.8

156

WPA44

NOMESCO Finland

Nursing home for palliative care

5.9

11.8

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

11.8

225

1368

P01AB01

ATC

metronidazole; oral, rectal

1.3

11.7

1353

11357

TPX15

NOMESCO Finland

Removal of vascular injection port

4.7

11.6

XGX10

NOMESCO Finland

Intrapleural ultrasonography

30.1

11.6

L01XK02

ATC

niraparib; oral

19.0

11.6

R07.3

ICD-10 Finland

Other chest pain

1.5

11.5

401

2796

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.7

11.5

218

1323

R03BA02

ATC

budesonide; inhalant

1.4

11.5

602

4521

J98.5

ICD-10 Finland

Diseases of mediastinum, not elsewhere classified

+∞

11.5

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

+∞

11.5

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.2

11.5

465

K65.0

ICD-10 Finland

Acute peritonitis

2.6

11.4

242

OAB43, ,

SPAT

0.6

11.4

205

3312

H02AB09

ATC

hydrocortisone; systemic

2.2

11.4

401

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.1

11.4

149

A02BC01

ATC

omeprazole; systemic

1.3

11.4

1113

9142

A10AC01

ATC

insulin (human); parenteral

1.5

11.3

342

2317

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

11.3

356

2433

I34.1

ICD-10 Finland

Mitral (valve) prolapse

2.0

11.3

122

623

R03AC13

ATC

formoterol; inhalant

1.7

11.3

188

1101

155

Kela drug reimbursment

Afatinib and gefitinib

10.5

11.2

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.4

11.2

322

5188X

ICD-9 Finland

Other diseases of lung

4.3

11.2

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.6

11.2

234

1456

168

Kela drug reimbursment

Axitinib

25.1

11.1

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

11.1

1487

12680

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

2.8

11.1

189

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

11.1

794

6251

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

5.3

11.0

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

3.9

11.0

ZXA05

NOMESCO Finland

Left side

1.3

11.0

1024

8353

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

9.2

11.0

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

10.9

370

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

10.9

1121

9256

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

10.9

238

1498

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

10.8

661

5081

Angiography of the heart and coronary arteries

1.5

10.8

359

2480

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

3.4

10.8

113

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

3.0

10.8

154

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

10.7

350

2409

ZXA00

NOMESCO Finland

Right side

1.3

10.7

1100

9079

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.4

10.7

292

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

10.7

1300

10951

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

3.1

10.7

139

SPAT1301

SPAT

No procedures

1.3

10.7

1259

10567

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

3.7

10.7

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

3.0

10.7

155

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

3.3

10.7

119

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

10.7

106

526

5BA08, ,

NOMESCO Finland

3.8

10.6

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.9

10.6

166

I31.8

ICD-10 Finland

Other specified diseases of pericardium

12.9

10.6

K86.1

ICD-10 Finland

Other chronic pancreatitis

2.9

10.6

161

RD210, ,

NOMESCO Finland

2.6

10.6

234

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

8.0

10.6

EB4VA, ,

NOMESCO Finland

0.6

10.5

192

3091

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.6

10.5

229

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

10.5

641

4926

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

4.4

10.5

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.6

10.5

241

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

4.5

10.5

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

2.0

10.4

114

585

NA2AD

NOMESCO Finland

Thoracic spine CT examination

3.4

10.4

111

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

10.4

209

1289

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

10.4

268

1755

C45.9

ICD-10 Finland

Mesothelioma, unspecified

32.6

10.3

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

10.3

313

2124

R85

ICPC

Malignant neopl respiratory other

8.2

10.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

4.3

10.3

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

10.3

575

4359

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

4.9

10.2

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

10.2

244

1569

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

10.2

1056

8717

J01DA01

ATC

[U] cefalexin

1.2

10.1

2399

21667

WX704

NOMESCO Finland

Intubation

1.5

10.1

288

1926

WX250

NOMESCO Finland

Intercostal blockade

5.3

10.1

SPAT1229

SPAT

Assessment of need for aid

1.5

10.1

341

2365

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.8

10.1

135

742

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.8

10.0

177

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

3.0

10.0

150

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.5

10.0

235

J43.2

ICD-10 Finland

Centrilobular emphysema

4.6

10.0

N06DX01

ATC

memantine; oral

0.6

10.0

230

3507

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

4.0

9.9

RS220, ,

NOMESCO Finland

2.8

9.9

167

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

4.1

9.9

I30.8

ICD-10 Finland

Other forms of acute pericarditis

16.7

9.9

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.2

9.8

361

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

3.9

9.8

W06

ICD-10 Finland

Fall involving bed

2.7

9.8

191

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

2.6

9.8

220

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.8

9.7

152

875

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.1

9.7

126

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.1

9.7

126

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.6

9.7

203

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2.2

9.7

383

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

2.5

9.7

245

E87.6

ICD-10 Finland

Hypokalaemia

1.8

9.7

149

855

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

2.9

9.6

148

Z76.0

ICD-10 Finland

Issue of repeat prescription

0.7

9.6

554

7167

306

Kela drug reimbursment

Erythropoietin and darbepoetin

4.2

9.6

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.8

9.6

146

834

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.6

9.6

216

3025

Kela drug reimbursment

Calcium carbonate

3.2

9.6

112

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.0

9.5

105

541

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

8.4

9.5

B01AC04

ATC

clopidogrel; oral

1.3

9.5

842

6810

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.1

9.4

447

A04

ICPC

Weakness/tiredness general

1.3

9.4

621

4824

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.0

9.4

502

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.6

9.4

245

1608

GA2CT

NOMESCO Finland

Pleural biopsy with CT guidance

100.2

9.4

ZZA00

NOMESCO Finland

Split skin graft

1.8

9.4

131

729

GDG10

NOMESCO Finland

Bilateral transplantation of lung

30.1

9.4

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.7

9.4

178

5120A

ICD-9 Finland

Pneumothorax, Spontaneous tension pneumothorax

+∞

9.4

8000/3-C38.4

ICD-O-3

Neoplasm, malignant of pleura, NOS

+∞

9.4

51299

ICD-8 Finland

Spontaneous pneumothorax

+∞

9.4

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.6

9.4

219

1403

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

2.9

9.3

140

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.4

9.3

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

9.3

324

2261

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

3.2

9.3

109

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

2.4

9.3

250

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.5

9.3

220

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

3.1

9.2

125

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.5

9.2

227

R03AC18

ATC

indacaterol; inhalant

3.1

9.2

115

20199

ICD-8 Finland

Hodgkin's disease

13.7

9.2

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.7

9.2

159

944

RJ411, ,

NOMESCO Finland

3.7

9.1

J05AB11

ATC

valaciclovir; oral

1.4

9.1

490

3689

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

3.9

9.1

Z72.0

ICD-10 Finland

Tobacco use

2.1

9.1

393

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

5.0

9.1

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

3.1

9.1

121

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

1.9

9.1

104

544

PD5AD

NOMESCO Finland

CT of aorta

1.9

9.0

113

608

3004

Kela drug reimbursment

Osimertinib

15.6

9.0

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.2

9.0

106

GDA96

NOMESCO Finland

Other incision, excision of lesion or repair of lung

36.8

9.0

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

9.0

160

956

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

9.0

338

2394

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

3.5

8.9

A15.6

ICD-10 Finland

Tuberculous pleurisy, confirmed bacteriologically and histologically

24.0

8.9

R03BB02

ATC

oxitropium bromide; inhalant

2.8

8.9

155

J45.8

ICD-10 Finland

Mixed asthma

1.9

8.9

107

569

L02BG03

ATC

anastrozole; oral

2.4

8.9

243

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.0

8.8

486

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

3.0

8.8

123

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

4.9

8.8

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

2.9

8.8

134

ZXC40

NOMESCO Finland

Use of ultrasound

3.5

8.8

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

4.0

8.8

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

9.5

8.8

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

2.7

8.7

162

A12BA01

ATC

potassium chloride; oral

1.6

8.7

223

1458

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

2.0

8.7

440

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

8.7

153

912

R03AK11

ATC

formoterol and fluticasone; inhalant

2.1

8.7

380

RS222, ,

NOMESCO Finland

2.5

8.7

215

A07AA02

ATC

nystatin; oral

1.6

8.7

223

1460

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

3.0

8.7

119

1519, ,

Kela drug reimbursment

14.0

8.7

Z94.2

ICD-10 Finland

Lung transplant status

14.0

8.7

L01XE17

ATC

[U] axitinib

50.1

8.7

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

1.9

8.6

104

553

WPA11

NOMESCO Finland

Developing a plan for palliative care

4.8

8.6

N07BB01

ATC

disulfiram; oral

1.8

8.6

117

648

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.5

8.5

211

OAA67, ,

SPAT

0.6

8.5

114

1985

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.4

8.5

329

2343

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

3.4

8.5

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

8.4

399

2942

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

7.3

8.4

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.2

8.4

287

J18

ICD-10 Finland

Pneumonia, organism unspecified

2.7

8.4

160

XX9XW, ,

NOMESCO Finland

3.6

8.4

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

4.5

8.4

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.9

8.4

106

574

L01XE03

ATC

[U] erlotinib

6.7

8.3

9053/3-C38.4

ICD-O-3

Mesothelioma, biphasic, malignant of pleura, NOS

+∞

8.3

GAC40

NOMESCO Finland

Pleurodesis with decortication

+∞

8.3

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

8.3

462

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.1

8.3

347

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

2.7

8.3

150

Z31.5

ICD-10 Finland

Genetic counselling

1.8

8.3

118

663

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.9

8.2

123

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

8.2

510

3925

H3601, E103,

ICD-10 Finland

3.4

8.2

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

3.2

8.2

JAL00

NOMESCO Finland

Biopsy of peritoneum

4.2

8.2

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

3.9

8.1

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

4.5

8.1

RJ414, ,

NOMESCO Finland

4.8

8.1

I31.1

ICD-10 Finland

Chronic constrictive pericarditis

33.4

8.1

158

Kela drug reimbursment

Everolimus

8.1

1XC02, ,

NOMESCO Finland

3.2

8.1

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

1.8

8.0

109

603

R03DA04

ATC

theophylline; systemic, rectal

1.5

8.0

243

1649

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

2.1

8.0

372

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.6

8.0

175

1104

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.6

8.0

170

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

2.9

8.0

125

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.0

8.0

421

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.7

7.9

148

897

SPAT1172

SPAT

Guidance concerning hydration

1.8

7.9

114

642

GD1UN

NOMESCO Finland

Lung circulation SPECT

3.3

7.9

A02BA02

ATC

ranitidine; systemic

1.3

7.9

795

6521

GEA00

NOMESCO Finland

Mediastinoscopy

3.9

7.9

WX402

NOMESCO Finland

General anaesthesia

1.3

7.9

715

5792

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

6.6

7.9

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

13.0

7.9

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

7.8

187

1205

N05BA01

ATC

diazepam; systemic, rectal

1.3

7.8

463

3537

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

7.8

114

645

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

7.8

272

1899

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

3.5

7.8

1243

FHL

Bronchoscopy and other therapeutic procedure

8.4

7.8

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.2

7.8

290

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

9.4

7.8

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

7.8

237

1612

R2110

NOMESCO Finland

Giving the first information

1.6

7.8

185

1192

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

7.8

231

1563

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.8

7.8

109

610

Z94.1

ICD-10 Finland

Heart transplant status

6.9

7.8

GDC00

NOMESCO Finland

Lobectomy of lung

3.0

7.8

111

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

3.0

7.8

111

A10AB01

ATC

insulin (human); parenteral

1.8

7.7

116

662

N03AX12

ATC

[U] gabapentin; oral

1.3

7.7

559

4395

ZZR10

NOMESCO Finland

Flap of skin and muscle

3.0

7.7

106

SPAT1251

SPAT

Organisation of medication

1.7

7.7

146

889

L01XE13

ATC

[U] afatinib

15.0

7.7

340

Kela drug reimbursment

Everolimus

15.0

7.7

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.9

7.7

539

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.9

7.7

468

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

2.6

7.7

156

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

7.7

1472

12914

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

3.5

7.7

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.2

7.7

881

7334

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

2.1

7.7

305

A10AA01, ,

ATC

2.0

7.7

406

WPA44, ,

SPAT

3.4

7.7

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.1

7.6

332

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

1.8

7.6

115

658

J80

ICD-10 Finland

Adult respiratory distress syndrome

4.0

7.6

SPAT1211

SPAT

Application of soft bandage

1.4

7.6

318

2297

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.1

7.6

353

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.1

7.6

300

L01EX07

ATC

cabozantinib; oral

6.7

7.6

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

25.0

7.6

C45.1

ICD-10 Finland

Mesothelioma of peritoneum

25.0

7.6

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

11.8

7.6

WX720

NOMESCO Finland

Own respiration

1.6

7.5

173

1105

EB1VA, ,

NOMESCO Finland

0.7

7.5

299

4108

OAB48, ,

SPAT

0.6

7.5

112

1895

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.2

7.5

262

E87.7

ICD-10 Finland

Fluid overload

10.0

7.5

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

1.9

7.5

515

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.6

7.5

164

SPAT1310

SPAT

Counselling related to known health issue

1.2

7.5

1128

9664

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.3

7.5

250

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

7.4

209

1398

L04AA13

ATC

[U] leflunomide

2.0

7.4

356

C08CA01

ATC

amlodipine; oral

1.2

7.4

1742

15558

156

Kela drug reimbursment

Lapatinib

80.2

7.4

N06AB04

ATC

citalopram; systemic

1.3

7.4

701

5704

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

3.5

7.4

ZX114

NOMESCO Finland

Intramuscular

2.4

7.4

195

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

2.7

7.4

142

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.7

7.4

137

830

I20.00

ICD-10 Finland

Unstable angina

1.6

7.4

151

938

XG460

NOMESCO Finland

Short time oxymetry

2.1

7.4

330

WX726

NOMESCO Finland

High-flow oxygen therapy

7.6

7.4

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.7

7.4

118

687

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

7.4

656

5299

OAB42, ,

SPAT

0.7

7.4

228

3274

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

7.3

1384

12113

ZX121

NOMESCO Finland

Central venous catheter

4.0

7.3

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.0

7.3

351

D68.8

ICD-10 Finland

Other specified coagulation defects

2.7

7.3

137

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.1

7.3

298

I43.1*E85.9

ICD-10 Finland

Cardiac amyloidosis

8.4

7.3

R03AC03

ATC

terbutaline; inhalant

1.3

7.3

432

3301

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

3.0

7.3

5111A

ICD-9 Finland

Pleurisy, With effusion, with mention of a bacterial cause other than tuberculosis[PLEURITIS EXSUDATIVA BACTERICA]

+∞

7.3

GDD20

NOMESCO Finland

Extended pneumonectomy

+∞

7.3

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

10.9

7.3

SPAT1097

SPAT

Recording of ECG

1.3

7.3

576

4583

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

2.7

7.3

132

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

4.1

7.3

SPAT1325

SPAT

Vaccination

1.2

7.3

1383

12115

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

7.2

274

1945

E85.9

ICD-10 Finland

Amyloidosis, unspecified

6.2

7.2

C10AA07

ATC

rosuvastatin; oral

0.8

7.2

932

10960

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

7.2

1215

10519

NGQ20

NOMESCO Finland

Amputation of lower leg

2.7

7.2

133

I65.3

ICD-10 Finland

Occlusion and stenosis of multiple and bilateral precerebral arteries

4.5

7.2

K92.1

ICD-10 Finland

Melaena

1.4

7.2

260

1831

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

3.9

7.2

198

Kela drug reimbursment

Sorafenib

3.9

7.2

R03BB07

ATC

umeclidinium bromide; inhalant

2.8

7.1

122

E000001, ,

ATC

1.3

7.1

654

5300

JBA10

NOMESCO Finland

Transabdominal biopsy or excision of lesion of diaphragm

20.0

7.1

9650/3-C77.0

ICD-O-3

Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck

20.0

7.1

389

Kela drug reimbursment

Olaparib

20.0

7.1

1511

Kela drug reimbursment

Olaparib

20.0

7.1

GAW97

NOMESCO Finland

Other thoracoscopic operation on chest wall, pleura and diaphragm

20.0

7.1

FE2AT

NOMESCO Finland

Pericardial cathetrisation with ultrasound guidance

20.0

7.1

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.3

7.1

500

3915

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.1

7.1

308

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.1

2375

21834

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

2.4

7.1

205

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.2

7.1

256

PD5BD

NOMESCO Finland

Extensive CT of aorta

1.9

7.1

475

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

7.1

173

1123

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

5.6

7.0

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.5

7.0

235

1629

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.1

7.0

323

J46

ICD-10 Finland

Status asthmaticus

1.8

7.0

498

4919X

ICD-9 Finland

Chronic bronchitis, Unspecified chronic bronchitis

4.2

7.0

B03BA03

ATC

hydroxocobalamin; parenteral

1.4

7.0

267

1898

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

7.0

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

7.0

107

616

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.7

6.9

132

806

KAC10

NOMESCO Finland

Total nephrectomy with capsule

2.6

6.9

153

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

6.9

214

1461

-54

ICPC

Repair/fix-suture/cast/prosth device

1.9

6.9

450

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

2.5

6.9

159

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.7

6.9

110

640

ZX100

NOMESCO Finland

Oral

2.1

6.9

272

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

1.9

6.9

415

N07BA03

ATC

varenicline; oral

1.7

6.9

111

648

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

7.5

6.9

XG405

NOMESCO Finland

Education on PEF monitoring

2.3

6.9

227

V03AE03

ATC

lanthanum carbonate; oral

4.0

6.9

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.4

6.9

249

1753

PE1AT

NOMESCO Finland

Femoral artery PTA

2.1

6.9

319

A01AB09

ATC

miconazole; local oral

1.4

6.9

299

2176

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

1.9

6.9

444

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

3.6

6.9

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

6.9

1419

12511

SPAT1234

SPAT

Support of social functional capacity

1.5

6.8

232

1613

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

6.8

914

7727

NG1AA, ,

SPAT

0.5

6.8

1276

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

3.3

6.8

4910A

ICD-9 Finland

Chronic bronchitis, Simple chronic bronchitis

4.1

6.8

1514, ,

Kela drug reimbursment

9.3

6.8

3002

Kela drug reimbursment

Ribociclib

9.3

6.8

159

Kela drug reimbursment

Pazopanib

6.1

6.8

SPAT1122

SPAT

Ascites puncture

40.1

6.8

A07AA11

ATC

rifaximin; oral

4.3

6.7

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

4.3

6.7

X99.0

ICD-10 Finland

Assault by sharp object by spouse or partner

16.7

6.7

K92.0

ICD-10 Finland

Haematemesis

1.7

6.7

110

645

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

6.7

305

2235

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.3

6.7

223

L88

ICPC

Rheumatoid/seropositive arthritis

1.7

6.7

120

721

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.4

6.7

325

2408

RJ420, ,

NOMESCO Finland

3.5

6.7

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.5

6.7

K70.4

ICD-10 Finland

Alcoholic hepatic failure

3.5

6.7

WX900

NOMESCO Finland

Resuscitation

3.1

6.7

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.1

6.7

302

K86.3

ICD-10 Finland

Pseudocyst of pancreas

3.4

6.7

R04.0

ICD-10 Finland

Epistaxis

1.4

6.7

336

2505

SPAT1125

SPAT

Stoma care and guidance

1.9

6.7

427

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

2.8

6.7

110

SPAT1153

SPAT

Removal of sutures

1.2

6.7

1232

10746

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

2.5

6.7

162

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.7

6.7

112

662

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.8

6.7

101

580

AA1

Conventional CABG

1.7

6.6

103

595

ZY010

NOMESCO Finland

Hospital outpatient

1.7

6.6

122

739

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

2.3

6.6

193

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

6.6

129

793

R03BA08

ATC

ciclesonide; inhalant

1.4

6.6

241

1699

M34.1

ICD-10 Finland

CR(E)ST syndrome

4.0

6.6

4019X

ICD-9 Finland

Essential hypertension, Unspecified

1.6

6.6

158

1021

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

2.1

6.6

304

5822

FHL

Exploratory thoracotomy and small procedure (eg lung suture)

12.2

6.6

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.6

6.6

137

857

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

3.2

6.6

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

8.7

6.5

L15

ICPC

Knee symptom/complaint

0.8

6.5

591

7234

E66.00

ICD-10 Finland

Metabolic syndrome

1.5

6.5

172

1136

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

10.0

6.5

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

10.0

6.5

AP3

Catheterization of the right and left side of the heart

3.8

6.5

H3600, E103,

ICD-10 Finland

2.8

6.5

106

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.0

6.5

319

R05

ICPC

Cough

1.2

6.5

820

6887

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

2.5

6.5

164

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

2.1

6.5

279

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

6.5

420

3253

J47

ICD-10 Finland

Bronchiectasis

1.9

6.5

382

C08DA01

ATC

verapamil; systemic

1.5

6.5

165

1082

R07.1

ICD-10 Finland

Chest pain on breathing

2.2

6.4

221

A10BH05

ATC

linagliptin; oral

1.4

6.4

240

1700

C08DB01

ATC

diltiazem; oral

1.4

6.4

269

1945

K83

ICPC

Heart valve disease NOS

2.2

6.4

234

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

3.2

6.4

I27.0

ICD-10 Finland

Primary pulmonary hypertension

7.4

6.4

JJC00

NOMESCO Finland

Allogenic transplantation of liver

7.4

6.4

E86

ICD-10 Finland

Volume depletion

1.7

6.4

122

747

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

2.2

6.4

248

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.7

6.3

166

2462

WF003

NOMESCO Finland

Adjuvant radiotherapy

1.7

6.3

114

687

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

1.9

6.3

378

C34.35

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma

8.1

6.3

S42.0

ICD-10 Finland

Fracture of clavicle

1.8

6.3

552

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

2.8

6.3

108

5100A

ICD-9 Finland

Empyema, With fistula

11.0

6.3

S27.2

ICD-10 Finland

Traumatic haemopneumothorax

5.5

6.3

J01FA15

ATC

telithromycin; oral

1.4

6.3

277

2021

WX610

NOMESCO Finland

Patient controlled analgesia

3.2

6.3

WGA11

NOMESCO Finland

Planning of pain management

3.2

6.3

K72.9

ICD-10 Finland

Hepatic failure, unspecified

2.9

6.3

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

+∞

6.2

J99.0

ICD-10 Finland

Rheumatoid lung disease

+∞

6.2

C45

ICD-10 Finland

Mesothelioma

+∞

6.2

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

6.2

309

2298

361

Kela drug reimbursment

Axitinib

26.7

6.2

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

6.2

210

1460

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.0

6.2

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.7

6.2

108

645

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

2.2

6.2

231

7862A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Cough

2.8

6.2

109

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

6.2

232

1645

J20

ICD-10 Finland

Acute bronchitis

1.4

6.2

310

2310

N07BC02

ATC

methadone; systemic

3.7

6.2

F10.24

ICD-10 Finland

Alcohol depence active use

2.2

6.2

212

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

2.5

6.2

138

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

2.7

6.2

115

R52.1

ICD-10 Finland

Chronic intractable pain

2.7

6.2

115

TJD20

NOMESCO Finland

Change of gastrostomy tube

3.5

6.1

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.7

6.1

101

594

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

6.1

990

8517

R60.1

ICD-10 Finland

Generalized oedema

2.8

6.1

104

A06AH05

ATC

naldemedine; oral

5.7

6.1

A29

ICPC

General symptom/complaint other

1.3

6.1

527

4237

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

7.7

6.1

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.0

6.1

286

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

2.5

6.1

151

JEA00

NOMESCO Finland

Appendectomy

1.5

6.1

171

1146

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

2.8

6.1

XX2RW, ,

NOMESCO Finland

2.2

6.1

220

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

4.1

6.1

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

4.1

6.1

I95.9

ICD-10 Finland

Hypotension, unspecified

1.9

6.1

412

3A422, ,

NOMESCO Finland

12.5

6.1

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.8

6.1

522

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

8.6

6.0

L01EF02

ATC

ribociclib; oral

8.6

6.0

205

Kela drug reimbursment

Chronic hypertension

1.2

6.0

1350

11958

341

Kela drug reimbursment

Afatinib and gefitinib

10.0

6.0

L01XE26

ATC

[U] cabozantinib

10.0

6.0

PJA10

NOMESCO Finland

Exploration of lymph nodes

2.2

6.0

221

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.1

6.0

274

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

2.4

6.0

152

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

180

56.72

319.35

1.4

1.2

54.19

2035.75

u/l

0.53

154

(3023368) Bacteria identified in Blood by Culture

2559

13030

3.17

318.74

6.5

4.3

—

(3023383) Lactate [Moles/volume] in Pleural fluid

392

82.30

307.65

1.5

1.2

3.71

2.64

mmol/l

2.12

364

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1652

5372

4.23

307.65

4.2

244.06

246.62

u/l

0.28

1603

5053

(3035880) pH of Pleural fluid

613

123

57.33

307.65

1.5

1.2

7.39

7.45

2.38

488

(3001893) Eosinophils/Leukocytes in Pleural fluid

350

56.45

307.65

1.6

1.3

3.30

3.22

0.02

303

(3026051) Granulocytes/Leukocytes in Pleural fluid

279

59.33

307.65

1.6

1.1

22.34

27.50

0.53

246

(3036782) Glucose [Moles/volume] in Pleural fluid

993

244

51.60

307.65

1.6

1.2

5.95

7.10

mmol/l

5.03

936

228

(3042010) Triglyceride [Moles/volume] in Pleural fluid

204

59.25

307.65

1.4

1.2

1.67

4.01

mmol/l

0.31

175

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

895

125

88.62

307.65

1.4

1.1

13.33

14.93

u/l

0.26

849

100

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

771

125

73.87

307.65

1.5

1.4

12.86

14.19

u/l

1.04

745

118

(3003434) Protein [Mass/volume] in Pleural fluid

1474

351

61.27

307.65

1.8

1.2

35.08

26.90

g/l

23.72

1401

291

(3005532) Lymphocytes/Leukocytes in Pleural fluid

395

46.36

307.65

1.6

1.2

65.57

57.84

1.07

341

(40768806) Pleura Pathology biopsy report

1119

242

60.75

307.65

1.9

1.2

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

187

62.83

307.65

1.7

1.2

13.64

5.85

2.23

(3045788) Cell count panel - Pleural fluid

991

272

46.14

307.65

1.8

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

362

109.04

307.65

1.4

1.1

482.91

121.23

ug/l

1.65

198

(3042936) Bacteria identified in Isolate by Culture

1919

5727

5.03

307.65

2.7

2.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

744

1090

7.95

307.65

1.8

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

860

734

14.18

307.65

1.9

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1549

3873

5.52

307.65

2.8

2.7

63.36

66.19

g/l

31.42

1479

3468

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1103

1338

10.52

307.65

2.8

2.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1077

206

67.92

307.65

1.5

1.2

393.54

361.30

u/l

0.19

1039

192

(3000919) Neutrophils/Leukocytes in Pleural fluid

315

53.60

307.65

1.6

1.3

17.34

34.47

3.83

291

(3041918) Cholesterol [Moles/volume] in Pleural fluid

214

46.71

307.65

1.4

1.2

1.73

1.27

mmol/l

0.71

186

(3028308) Erythrocytes [#/volume] in Pleural fluid

1101

292

49.23

307.65

1.8

1.2

69593.14

17299.48

e6/l

6.01

724

154

(3023199) Leukocytes [#/volume] in Pleural fluid

1250

332

51.29

307.65

1.8

1.2

2069.48

2323.77

e6/l

0.12

1010

217

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

151

65.01

274.57

1.6

1.3

71.86

74.21

0.14

131

(3042631) Mycobacterium sp identified in Specimen

361

482

8.04

257.03

2.5

2.7

—

(44786800) Granulocytes/Leukocytes in Body fluid

139

57.30

247.14

1.4

1.2

21.62

20.41

0.07

109

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

122

73.69

226.24

1.1

20.17

19.22

u/l

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1557

7049

2.83

221.99

5.3

3.1

0.81

0.82

mmol/l

2.26

1495

6578

(3032080) INR in Blood by Coagulation assay

3195

20754

2.76

216.84

26.7

19.5

1.39

1.36

inr

2.04

2825

17539

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1637

7781

2.71

210.23

2.6

1.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1142

4668

2.92

193.71

3.5

4.3

23.99

19.91

ug/l

0.20

951

3884

(3014891) Appearance of Pleural fluid

125

32.09

193.13

1.8

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

666

1985

3.75

190.03

2.3

1.8

3.82

2.65

ug/l

0.23

613

1726

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3148

21200

2.53

182.74

12.2

6.5

11.64

12.85

umol/l

5.48

3048

20199

(3019069) Monocytes/Leukocytes in Blood

2779

17754

2.42

180.41

9.5

6.3

9.49

9.17

5.15

2681

16450

(42870588) Differential panel, method unspecified - Blood

2252

13239

2.37

175.23

8.7

5.9

—

(3006504) Eosinophils/Leukocytes in Blood

2758

17722

2.39

174.25

9.4

6.2

2.54

2.87

13.29

2659

16417

(3002030) Lymphocytes/Leukocytes in Blood

2783

17999

2.38

172.52

9.4

6.2

21.54

26.04

80.19

2708

16886

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

398

868

4.92

171.31

1.6

—

(3022096) Basophils/Leukocytes in Blood

2746

17716

2.36

170.32

9.5

6.3

0.60

0.65

5.59

2646

16413

(3006315) Basophils [#/volume] in Blood

2895

19189

2.37

167.37

9.0

5.9

0.04

e9/l

1.35

2593

16110

(3001604) Monocytes [#/volume] in Blood

2885

19109

2.36

166.84

9.0

5.9

0.68

0.62

e9/l

18.66

2590

16026

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1410

6850

2.53

166.37

3.1

2.0

30.65

29.95

3.47

1376

6653

(3013115) Eosinophils [#/volume] in Blood

2940

19728

2.35

163.46

9.4

6.1

0.19

0.20

e9/l

2.28

2650

16810

(3013650) Neutrophils [#/volume] in Blood by Automated count

3131

21618

2.40

162.41

17.7

9.1

4.61

4.32

e9/l

6.80

2855

18505

(3019198) Lymphocytes [#/volume] in Blood

2913

19507

2.34

162.17

9.2

6.0

1.60

1.86

e9/l

9.12

2643

16765

(3018010) Neutrophils/Leukocytes in Blood

2713

17642

2.31

161.83

9.1

6.1

62.58

58.51

55.30

2641

16692

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1248

5846

2.56

157.90

2.4

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

557

1662

3.67

157.38

3.8

2.8

0.33

0.34

iu/ml

0.11

336

920

(3024561) Albumin [Mass/volume] in Serum or Plasma

2837

18997

2.28

154.83

8.9

5.1

31.39

34.84

g/l

150.42

2689

17678

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1248

5926

2.52

152.72

10.1

5.8

1.10

1.04

mmol/l

10.44

1179

5467

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2360

14762

2.23

150.93

5.0

3.3

2803.43

1806.37

ng/l

9.52

2186

12893

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

400

981

4.37

148.30

1.8

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1004

4353

2.67

147.82

12.3

6.6

12.72

11.24

mmol/l

5.86

955

4132

(4035726) Immunohistochemistry procedure

853

3417

2.84

146.38

1.5

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

399

998

4.28

144.07

1.8

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

292

568

5.42

142.93

1.5

2.0

23.61

25.19

ug/l

0.16

284

555

(3019977) pH of Arterial blood

1149

5395

2.51

142.79

9.3

7.0

7.42

0.38

731

2888

(3003396) Base excess in Arterial blood by calculation

1143

5365

2.50

142.06

9.2

6.9

1.63

0.69

mmol/l

10.70

964

4305

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1147

5419

2.49

140.36

9.3

7.0

5.22

5.00

kpa

8.91

1103

5188

(3027801) Oxygen [Partial pressure] in Arterial blood

1146

5417

2.48

140.04

9.3

7.0

11.15

12.22

kpa

11.77

1107

5186

(3009343) pH of Capillary blood

741

2855

2.90

136.03

6.3

3.4

7.42

0.07

651

2364

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1140

5458

2.45

134.84

2.4

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

346

817

4.50

134.43

1.7

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

751

2939

2.86

133.78

6.3

3.4

5.33

5.05

kpa

12.61

729

2764

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

311

678

4.85

133.34

1.9

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

953

4244

2.57

131.30

8.5

6.9

1.31

1.39

mmol/l

1.65

926

4140

(40758047) Lysozyme [Mass/volume] in Pleural fluid

40.17

129.93

1.2

1.1

8.67

13.21

mg/l

0.43

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3008

21440

2.16

129.40

14.3

7.3

1.20

1.21

mmol/l

16.16

2600

18456

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2775

19214

2.12

128.40

12.6

6.6

1.20

1.21

mmol/l

14.10

2626

17630

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

664

2507

2.93

125.93

6.0

3.2

2.78

1.53

mmol/l

12.93

540

1758

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

278

579

5.05

125.71

1.6

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

310

712

4.60

124.56

1.7

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2027

12727

2.06

119.42

3.7

2.6

58.55

67.60

u/l

0.76

1916

11769

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1346

7285

2.20

116.88

4.0

2.6

2.10

2.25

g/l

15.73

1262

6701

(3016502) Oxygen saturation in Arterial blood

1011

4860

2.38

116.52

9.8

7.2

94.56

95.54

3.78

985

4684

(3022948) Iron [Moles/volume] in Serum or Plasma

1398

7745

2.16

113.91

4.1

2.7

10.11

12.34

umol/l

31.34

1305

7183

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1269

6770

2.21

113.76

4.1

2.7

19.79

22.07

7.43

1195

6270

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

295

708

4.38

111.93

1.6

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

354

973

3.86

111.71

2.1

1.5

1.09

1.19

g/l

4.72

341

922

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

346

939

3.90

111.16

2.0

1.5

0.24

g/l

0.35

334

891

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

233

466

5.21

110.25

1.2

1.1

—

(1616796) Gas panel - Central venous blood

326

871

3.95

107.00

5.9

3.3

—

(3037522) Nuclear Ab [Titer] in Serum

919

4395

2.36

106.16

1.5

1.3

480.16

487.34

titre

0.05

256

970

(3009445) Proteinase 3 Ab [Units/volume] in Serum

480

1673

3.09

104.07

1.4

7.00

13.42

iu/ml

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

871

4115

2.38

103.18

2.5

2.1

0.17

0.20

g/l

19.93

803

3793

(3005719) IgG [Mass/volume] in Serum or Plasma

653

2703

2.65

102.63

3.2

2.8

10.87

10.60

g/l

0.66

614

2471

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

731

3224

2.51

100.58

2.0

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

731

3303

2.44

95.06

2.9

2.3

396.34

384.30

nmol/l

0.60

693

3033

(3044416) Complement C4 [Mass/volume] in Pleural fluid

46.37

93.43

1.2

1.0

0.07

0.06

g/l

—

(3018418) pH of Serum or Plasma

1941

12843

1.88

90.68

7.9

4.1

7.40

0.95

1544

9308

(46235355) HIV 1 and 2 tests - Meaningful Use set

829

4056

2.27

89.36

1.8

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2325

16385

1.85

87.96

6.4

4.3

47.14

102.92

ng/l

1.36

1996

12883

(3002032) Base excess in Venous blood by calculation

928

4785

2.18

87.74

6.8

3.6

1.99

1.56

mmol/l

2.89

819

4098

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

217

495

4.55

87.62

1.8

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

412

1448

3.03

87.57

1.6

1.8

36.61

38.97

u/l

1.19

354

1228

(3012501) Base excess in Blood by calculation

283

787

3.77

87.46

5.9

3.6

3.04

2.43

mmol/l

2.81

221

506

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

214

486

4.57

86.88

1.9

1.4

—

(3012544) pH of Venous blood

951

4974

2.15

86.58

6.8

3.7

7.37

7.38

1.30

623

2920

(3028026) IgM [Mass/volume] in Serum or Plasma

530

2143

2.66

86.57

2.2

2.0

1.28

1.39

g/l

0.42

492

1938

(3008152) Bicarbonate [Moles/volume] in Arterial blood

647

2882

2.45

86.28

9.4

6.1

25.13

24.15

mmol/l

7.61

629

2759

(3021447) Carbon dioxide [Partial pressure] in Venous blood

939

4903

2.15

85.77

6.8

3.6

5.95

5.76

kpa

6.32

908

4758

(3022313) Gas panel - Capillary blood

507

2019

2.70

85.31

6.6

3.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3100

24059

1.88

84.24

9.5

5.1

6.95

6.90

mmol/l

0.70

3039

22958

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

297

876

3.56

84.05

1.5

1.9

11.15

12.92

mg/l

1.52

280

796

(3002173) Hemoglobin [Mass/volume] in Arterial blood

882

4537

2.17

83.48

11.0

7.7

116.03

119.85

g/l

6.52

866

4432

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

396

1411

2.98

82.00

1.2

—

(3017181) Myelocytes/Leukocytes in Blood

741

3582

2.27

81.62

5.5

4.1

1.04

0.96

0.44

367

1158

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1324

7978

1.93

80.38

2.1

1.7

1.83

1.59

mg/l

1.54

1107

6270

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

550

2355

2.52

79.53

1.7

1.5

—

(3002179) Metamyelocytes/Leukocytes in Blood

708

3394

2.28

79.40

5.1

4.0

0.77

0.01

340

1085

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

788

3977

2.18

77.78

4.3

3.0

379.18

245.54

ng/l

4.92

747

3674

(3027945) Reticulocytes/Erythrocytes in Blood

1062

5995

2.00

77.66

3.1

2.5

1.91

1.75

4.87

951

5278

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1773

11853

1.81

76.51

3.0

2.4

3.35

2.90

mg/l

8.96

1551

10120

(3000991) Gas panel - Venous blood

798

4087

2.15

75.71

12.2

8.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

410

1566

2.78

74.47

4.2

2.6

25.35

24.33

mmol/l

4.73

405

1536

(3023419) Bacteria identified in Sputum by Culture

195

466

4.33

74.12

2.4

2.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

258

757

3.55

73.47

6.7

4.6

254.82

3666.75

iu/ml

0.81

110

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

329

1130

3.06

72.49

1.4

8.53

14.50

iu/ml

—

(3000494) Fungus identified in Specimen by Culture

831

4422

2.07

70.87

1.8

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

353

1281

2.90

70.47

11.3

3.5

258.60

74.40

u/ml

2.69

347

1238

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

148

295

5.15

70.15

1.7

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

721

3661

2.15

69.46

1.9

1.5

—

(3021440) Promyelocytes/Leukocytes in Blood

683

3417

2.17

68.25

5.6

4.2

0.11

0.12

0.19

311

998

(3026782) Osmolality of Urine

1357

8628

1.81

67.34

4.0

3.1

515.70

543.38

mosm/kgh2o

5.88

1224

7561

(3044640) Blood type and Crossmatch panel - Blood

1884

13175

1.73

67.05

3.9

2.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

312

1095

2.98

66.08

5.4

2.8

7.70

7.97

kpa

2.19

306

1062

(3025159) Blasts/Leukocytes in Blood

675

3402

2.15

66.05

5.6

4.3

0.11

0.14

0.21

290

924

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3541

29562

1.85

65.88

16.6

8.3

91.68

82.29

u/l

16.07

3443

27906

(3007853) Bacteria identified in Skin by Aerobe culture

860

4746

2.00

65.84

2.1

1.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

215

602

3.70

65.61

6.6

6.3

12.37

12.46

mg/l

0.09

202

552

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

393

1573

2.64

64.87

7.2

3.7

25.63

24.50

mmol/l

8.62

372

1405

(3017143) Hepatitis C virus Ab [Presence] in Serum

638

3169

2.18

64.70

1.9

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1733

12032

1.71

61.98

5.1

3.2

40.23

38.43

u/l

0.23

1650

11292

(3021901) Oxygen saturation in Capillary blood

274

930

3.07

61.48

4.6

2.5

87.88

89.26

2.09

267

898

(40760892) CBC W Ordered Manual Differential panel - Blood

1199

7527

1.80

61.05

7.4

4.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

569

2764

2.21

60.80

6.6

3.7

24.26

23.93

mmol/l

1.79

563

2715

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

167

416

4.13

60.05

3.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

156

371

4.32

59.63

1.8

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

758

4132

2.00

59.56

5.7

3.0

4.59

4.45

kpa

0.85

731

4002

(3023520) Reticulocytes [#/volume] in Blood

830

4680

1.94

59.08

3.1

2.5

70.22

67.14

e9/l

1.43

630

3475

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

523

2491

2.24

58.55

2.0

1.7

1.66

1.54

g/l

1.72

454

2128

(3023420) DNA double strand Ab [Units/volume] in Serum

338

1320

2.68

58.46

2.2

1.5

7.59

6.12

iu/ml

0.48

290

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

567

2792

2.18

58.44

11.0

8.8

24.84

23.99

mmol/l

6.27

543

2709

(3033658) Prothrombin time (PT) actual/Normal

1506

10198

1.71

58.21

8.7

4.2

79.99

83.49

5.90

1473

9993

(44790048) Parainfluenza type 2 nucleic acid detection

177

471

3.87

58.10

1.7

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

177

471

3.87

58.10

1.7

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

177

471

3.87

58.10

1.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

177

471

3.87

58.10

1.7

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

160

396

4.15

58.03

1.8

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

297

1096

2.83

57.27

3.1

2.4

3.65

3.61

g/l

0.16

287

1042

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

248

5.03

56.53

1.8

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

201

598

3.47

55.92

3.5

2.4

36411.67

2525.98

u/ml

0.45

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

113

219

5.26

55.28

1.8

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2367

18161

1.62

55.14

4.2

2.9

—

estimate

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

148

6.32

54.71

2.0

2.1

5657.21

6091.96

e6/l

0.02

101

(3037756) Immunofixation for Serum or Plasma

288

1071

2.80

54.70

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

272

982

2.88

54.59

1.6

1.5

16.19

16.32

iu/ml

0.00

204

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

110

212

5.29

54.15

1.8

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

355

1477

2.52

53.86

1.4

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

128

284

4.61

53.42

1.5

1.4

2.82

3.12

g/l

0.86

210

(3004809) Band form neutrophils/Leukocytes in Blood

226

747

3.13

53.00

4.3

3.5

1.46

1.59

0.25

208

653

(3031040) Bacteria [#/volume] in Urine by Automated count

3127

25847

1.65

52.63

6.4

5.2

1020.47

1733.12

e6/l

0.49

453

(3021879) Hepatitis B virus core Ab [Presence] in Serum

443

2055

2.28

52.62

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

399

1771

2.37

52.51

3.5

3.4

55.01

52.82

mg/l

0.10

331

1540

(3024139) IgG subclass 3 [Mass/volume] in Serum

127

284

4.57

52.49

1.5

1.4

0.46

0.43

g/l

0.22

210

(3027135) IgG subclass 1 [Mass/volume] in Serum

127

284

4.57

52.49

1.5

1.4

6.90

g/l

0.01

211

(3034860) Kappa light chains.free [Mass/volume] in Serum

399

1775

2.37

52.23

3.5

3.4

139.05

85.48

mg/l

0.29

332

1540

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

133

313

4.35

51.54

1.9

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

1458

10049

1.66

51.28

3.6

2.8

4.95

4.45

e6/l

0.58

1352

9155

(3023183) Ammonium ion [Moles/volume] in Plasma

261

953

2.84

51.26

3.4

2.5

32.05

34.47

umol/l

0.80

237

841

(3015377) Calcium [Moles/volume] in Serum or Plasma

1933

14286

1.61

51.26

6.1

3.5

2.33

2.35

mmol/l

10.41

1792

12845

(4062490) Immunoglobulin typing, IgG

125

282

4.53

51.11

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1458

10057

1.66

51.08

3.7

2.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

139

346

4.11

50.03

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

525

2668

2.09

49.45

12.0

9.3

15.34

15.85

3.75

516

2578

(3024980) IgG subclass 4 [Mass/volume] in Serum

173

507

3.51

49.25

1.7

1.6

0.77

0.92

g/l

0.81

128

406

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1289

8690

1.67

48.94

6.3

4.2

370.26

545.32

ng/l

0.63

1161

7519

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

200

645

3.20

48.86

1.5

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

566

2975

2.03

48.60

2.1

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

620

3366

1.97

48.57

6.0

3.9

127.22

97.66

ng/l

6.62

539

2877

(3015171) Extractable nuclear Ab [Units/volume] in Serum

292

1165

2.61

48.23

1.3

1.2

0.94

0.42

u/ml

0.80

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

784

4609

1.84

48.15

3.5

2.8

10.17

9.56

umol/l

0.31

685

4091

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

361

1595

2.37

47.89

3.4

3.3

37.57

3.51

ratio

0.58

222

964

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

196

639

3.16

47.02

1.5

1.4

20.03

14.80

u/ml

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

580

3118

1.98

46.64

12.7

8.6

1.43

1.29

3.37

575

3099

(3026008) Bacteria identified in Urine by Culture

1778

13107

1.58

46.25

3.8

3.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

127

6.23

45.85

1.9

13942.24

22531.18

e6/l

0.21

(3022806) Fractional oxyhemoglobin in Capillary blood

162

478

3.48

45.64

2.1

1.8

88.48

89.26

0.82

162

472

(3002582) Erythrocytes [#/volume] in Urine

1900

14276

1.56

45.15

4.7

3.7

62.75

103.98

e6/l

1.32

1578

11104

(3044007) Cell count panel - Peritoneal fluid

127

6.15

44.69

2.0

1.8

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

156

458

3.49

44.29

6.6

3.8

89.97

30.85

u/ml

3.46

150

445

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

740

4380

1.82

44.12

5.5

3.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

379

1779

2.23

43.52

2.4

1.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

177

569

3.20

43.47

1.6

1.4

175.06

155.39

au/ml

1.17

178

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

127

329

3.94

43.30

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

127

329

3.94

43.30

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

127

329

3.94

43.30

1.7

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

283

1175

2.50

42.97

1.6

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

1666

12256

1.56

42.84

4.6

3.6

0.54

0.46

e6/l

0.97

1363

9204

(36304419) Bacteria [Presence] in Urine

1585

11533

1.57

42.76

4.4

3.5

78.60

232.67

estimate

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

259

1047

2.56

41.58

3.1

2.2

85.88

89.81

1.79

249

1017

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

551

3028

1.93

41.27

13.3

8.8

0.64

0.63

0.18

545

3008

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

207

752

2.84

40.99

1.3

1.2

560.00

284.18

titre

0.59

(3037692) Legionella sp identified in Specimen by Organism specific culture

113

6.18

40.34

1.6

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

332

1537

2.25

39.34

6.0

3.4

1.28

1.44

mmol/l

1.76

321

1509

(3047181) Lactate [Moles/volume] in Blood

297

1314

2.35

39.15

7.0

5.5

1.34

1.39

mmol/l

0.36

267

1171

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

235

934

2.60

39.05

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

235

934

2.60

39.05

1.5

1.3

—

(4281824) Cell count and differential, peritoneal fluid

117

308

3.87

39.02

1.3

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

190

4.76

38.97

3.5

3.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

694

4171

1.78

38.93

2.9

2.4

6.11

7.02

ug/l

0.95

600

3614

(3002331) Protein [Mass/volume] in Peritoneal fluid

6.50

38.73

1.5

1.3

29.07

24.65

g/l

1.08

(3018095) Leukocytes [#/volume] in Urine

2006

15602

1.51

38.68

5.6

4.3

147.28

111.89

e6/l

0.53

1611

11439

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

346

1655

2.18

37.80

2.1

1.8

—

(3003181) Sodium [Moles/volume] in Urine

218

849

2.65

37.74

1.6

1.4

54.32

61.97

mmol/l

2.32

172

682

(3007930) Methemoglobin/Hemoglobin.total in Blood

392

1973

2.08

37.52

7.1

5.0

0.84

0.86

0.62

376

1868

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

581

3354

1.84

37.14

6.3

3.9

1.21

1.22

mmol/l

3.66

539

2876

(3027456) Digoxin [Moles/volume] in Serum or Plasma

264

1140

2.40

36.74

3.4

3.2

0.85

0.80

nmol/l

0.82

210

888

(3004119) Hemoglobin [Mass/volume] in Venous blood

533

3022

1.86

36.03

6.3

3.1

118.49

127.57

g/l

16.49

513

2928

(3027273) Bicarbonate [Moles/volume] in Venous blood

427

2254

1.99

35.77

6.2

3.3

25.41

24.90

mmol/l

2.04

409

2170

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

411

2151

2.00

35.27

6.9

4.8

1.69

1.55

2.72

394

2039

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

159

545

2.99

35.00

1.3

1.2

315.03

282.36

u/ml

0.63

101

321

(3035933) Granulocytes/Leukocytes in Blood

188

706

2.73

34.96

4.2

3.0

60.66

58.55

1.24

188

706

(3021589) Normoblasts [#/volume] in Blood

2072

16441

1.47

34.94

22.0

12.0

0.00

e9/l

0.58

1718

13292

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

138

5.21

34.68

1.8

1.9

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

168

599

2.87

34.44

1.3

1.2

—

122.02

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

233

980

2.45

34.35

3.1

2.5

228.23

204.48

3.07

223

934

(3006184) Hemoglobin [Mass/volume] in Capillary blood

244

1050

2.40

34.20

3.7

2.1

119.67

127.84

g/l

5.35

195

819

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

140

5.14

34.12

1.8

—

(3026250) Tacrolimus [Mass/volume] in Blood

119

5.53

33.90

42.5

35.5

6.95

6.94

ug/l

0.02

106

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

138

5.14

33.65

1.8

1.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

102

271

3.83

33.61

2.4

22.91

27.96

iu/ml

0.26

(3026493) Urate [Moles/volume] in Serum or Plasma

1458

10846

1.50

33.59

4.4

3.0

378.00

359.98

umol/l

6.47

1258

9349

(3017569) Oxygen content in Arterial blood

233

4.05

33.24

2.2

1.9

15.57

15.88

0.37

233

(3035637) Corticotropin [Mass/volume] in Plasma

139

463

3.06

32.18

1.6

35.18

27.87

ng/l

0.43

139

463

(3019309) Folate [Moles/volume] in Red Blood Cells

1192

8575

1.53

31.89

2.1

1.8

1195.08

1146.93

nmol/l

0.91

939

6434

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

446

2482

1.88

31.80

7.6

3.9

47.27

46.66

0.19

437

2441

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2090

16829

1.44

31.44

4.6

3.1

225.95

152.97

ug/l

14.63

1941

15403

(3017354) Segmented neutrophils/Leukocytes in Blood

141

484

2.97

30.98

4.2

3.5

61.37

57.40

1.25

127

402

(3008757) Leukocyte morphology finding [Identifier] in Blood

137

463

3.02

30.93

5.7

3.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1712

13339

1.45

30.42

2.7

2.2

186.46

228.85

u/l

1.68

1631

12574

(3007164) IgA [Mass/volume] in Serum or Plasma

923

6359

1.56

29.75

1.8

1.5

3.02

2.67

g/l

4.12

639

3685

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

327

1675

2.02

29.69

2.6

2.1

423.77

755.25

ug/l

1.35

308

1600

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

384

2088

1.92

29.33

2.9

2.3

3.76

3.75

g/l

0.04

351

1874

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3143

27459

1.45

29.32

6.5

4.4

21.86

13.75

mm/h

79.06

2951

25356

(3007566) Smooth muscle Ab [Titer] in Serum

216

943

2.35

29.30

1.2

135.24

104.32

titre

0.22

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

384

2093

1.91

29.11

2.9

2.3

4.09

4.17

g/l

1.24

354

1880

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

384

2094

1.91

29.07

2.9

2.3

7.60

7.38

g/l

1.59

354

1876

(3048929) Epstein Barr virus Ab [Presence] in Serum

188

776

2.48

28.86

1.3

1.2

—

(3036489) Thrombin time

280

1369

2.11

28.81

2.8

2.0

21.96

21.31

1.19

257

1261

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

192

4.12

28.59

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

192

4.12

28.59

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

192

4.12

28.59

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

218

966

2.32

28.58

3.1

3.3

409.65

897.55

u/ml

0.78

194

888

(3042733) HLA Ab [Presence] in Serum

6.13

27.96

4.2

4.6

—

(3039000) Anion gap in Blood by calculation

207

908

2.34

27.78

7.9

6.5

10.81

11.57

mmol/l

3.13

192

808

(3018572) Chloride [Moles/volume] in Blood

207

908

2.34

27.78

8.0

6.6

104.40

105.33

mmol/l

1.77

192

808

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

192

4.06

27.74

1.8

1.7

—

(3037121) Protein [Mass/volume] in Urine

297

1508

2.04

27.61

3.6

3.4

1105.35

416.23

mg/l

0.81

159

669

(3000012) Reticulocyte production index

182

757

2.46

27.49

2.2

2.1

0.99

0.87

1.30

146

524

(3026692) Albumin [Mass/volume] in Peritoneal fluid

116

5.05

27.47

1.4

15.57

12.79

g/l

1.30

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

358

1944

1.91

27.41

2.9

2.4

3.18

2.92

g/l

5.21

327

1730

(40758558) Short blood count panel - Blood

1506

11663

1.43

26.76

12.8

6.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

229

3.72

26.73

1.6

2.2

—

(3011412) CD3 cells [#/volume] in Blood

297

3.35

26.57

2.2

2.1

872.32

1133.50

e6/l

2.52

264

(40761536) Microorganisms panel - Urine sediment

484

2912

1.74

26.47

5.8

4.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1103

14581

0.68

26.34

2.2

2.0

1.35

1.31

mmol/l

0.91

898

12060

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

336

1822

1.91

25.81

3.0

2.4

10.31

10.27

g/l

0.07

302

1581

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

332

1794

1.92

25.78

2.9

2.5

0.75

1.06

g/l

1.14

287

1508

(3043409) Potassium [Moles/volume] in Arterial blood

258

1277

2.08

25.69

7.2

3.6

3.99

3.92

mmol/l

1.73

253

1265

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

593

3811

1.64

25.25

3.1

2.5

40.52

39.17

u/l

0.11

510

3210

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2597

22225

1.39

25.10

4.9

3.3

75.56

55.87

u/l

10.19

2419

20446

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

261

3.42

24.70

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

101

328

3.13

24.48

1.3

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

321

1746

1.90

24.41

2.8

3.3

728.78

2559.72

u/ml

0.64

273

1514

(3010375) cycloSPORINE [Mass/volume] in Blood

133

4.48

24.26

30.5

26.9

119.11

114.73

ug/l

0.19

111

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

286

1504

1.96

24.05

3.0

2.3

0.03

g/l

0.12

253

1334

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

238

1176

2.08

23.80

4.2

3.1

2.09

1.73

mg/l

5.64

218

1031

(21494890) Protein electrophoresis panel - 24 hour Urine

133

512

2.65

23.62

2.5

2.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

9.38

23.52

1.1

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

176

779

2.31

23.16

1.4

1.2

1.25

3.84

u/ml

0.90

(1175426) CD3 cells/Lymphocytes in Blood

231

3.46

22.69

1.7

2.1

68.82

72.01

0.81

214

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

443

2710

1.70

22.69

1.6

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

274

1449

1.95

22.66

3.1

2.3

0.00

g/l

0.50

238

1250

(3052851) Hemolysis interference index of Serum or Plasma

235

1182

2.04

22.40

4.4

3.4

1.71

1.77

index

0.07

146

606

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

194

910

2.18

22.20

1.5

1.2

3.04

5.15

u/ml

0.90

133

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

256

1343

1.96

21.67

3.2

2.4

0.00

g/l

-0.00

238

1246

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

207

3.52

21.24

4.5

3.1

1.62

1.25

0.81

207

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

803

5729

1.49

21.19

1.4

1.3

64.39

35.55

iu/ml

2.72

269

1709

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

191

908

2.15

21.14

1.4

1.2

3.43

2.78

u/ml

0.24

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

195

951

2.10

20.21

1.4

1.2

31.08

42.30

u/ml

0.34

(3003129) Base excess in Capillary blood by calculation

125

509

2.50

19.83

3.5

2.1

1.14

-0.03

mmol/l

2.24

120

488

(3024891) Influenza virus A+B Ag [Presence] in Specimen

174

818

2.17

19.83

1.2

1.1

—

(40768804) Tissue Pathology biopsy report

1787

14778

1.34

19.62

2.6

2.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

105

398

2.68

19.29

1.2

61.79

68.21

u/l

0.29

349

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.90

19.14

10.6

13.0

5.68

5.15

mmol/l

0.26

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

123

506

2.47

19.11

1.4

1.5

417.94

208.07

pmol/l

2.03

118

492

(40768446) Kidney Pathology biopsy report

133

4.02

19.02

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

145

645

2.29

18.91

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

107

414

2.62

18.88

4.5

3.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

183

896

2.09

18.79

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

180

882

2.08

18.44

1.4

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2081

17746

1.31

17.88

3.1

2.4

—

(21494814) CD8 cells/Lymphocytes in Specimen

126

4.00

17.86

1.8

2.0

29.22

31.37

0.35

126

(3017732) Neutrophils [#/volume] in Blood

645

4553

1.48

17.70

4.3

3.3

5.22

4.91

e9/l

0.26

552

3789

(3015736) pH of Urine

1920

16212

1.32

17.63

4.6

3.7

6.29

6.26

0.60

1058

8827

(3014271) Vancomycin [Susceptibility]

251

3.02

17.37

2.5

3.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

300

2.83

17.32

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

306

2.81

17.27

1.4

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

143

3.74

17.23

1.2

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1125

8806

1.37

17.21

4.3

3.1

2.49

2.46

mmol/l

13.32

1016

7850

(3020876) Protein [Mass/time] in 24 hour Urine

136

615

2.25

17.09

2.9

2.4

1.27

1.15

g/24h

0.23

355

(3004451) EKG impression Narrative

254

2.99

17.02

1.2

—

(3024928) Oxygen saturation in Venous blood

220

1192

1.89

16.93

5.3

2.7

63.32

59.90

1.42

209

1142

(3008536) Aspergillus sp Ab [Presence] in Serum

4.96

16.86

1.8

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

256

2.96

16.79

1.1

276.36

118.57

titre

0.49

(3019225) pH of Specimen

594

4166

1.49

16.78

7.4

4.6

7.37

7.36

0.67

484

2968

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

113

481

2.38

16.35

1.1

1.72

1.53

g/l

3.25

104

438

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

230

3.03

16.12

1.4

1.3

24.67

29.47

u/l

0.63

186

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

935

7176

1.38

16.01

4.3

3.4

1.72

1.83

e6/l

0.19

526

3716

(3029937) Albumin [Presence] in Urine by Test strip

1411

11527

1.32

16.00

5.5

4.3

0.00

estimate

0.17

533

3750

(3025941) Bacteria identified in Stool by Culture

286

1711

1.72

15.82

1.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

374

2.54

15.73

1.5

1.2

95.96

48.77

u/ml

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

197

3.18

15.71

2.5

2.0

0.44

0.67

e9/l

2.39

188

(3021601) Nitrite [Presence] in Urine by Test strip

2295

20078

1.28

15.29

5.4

4.2

0.00

estimate

1.08

613

4220

(3009261) Glucose [Presence] in Urine by Test strip

2332

20459

1.28

15.13

5.4

4.2

0.00

0.09

estimate

0.58

584

4019

(4015189) Microbial culture of sputum

4.30

14.98

1.6

1.9

—

(3035350) Ketones [Presence] in Urine by Test strip

2317

20339

1.28

14.84

5.4

4.2

6.46

3.51

estimate

0.35

622

4355

(3024471) HLA-A [Type]

4.42

14.70

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

228

2.92

14.52

1.7

1.6

7.44

7.51

u/l

0.01

180

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

118

540

2.22

14.46

1.1

—

(3024932) HLA-DR beta [Type]

4.46

14.46

1.1

—

(3044927) Protein electrophoresis panel - Urine

115

525

2.22

14.18

1.2

—

(3000492) Spirometry study

433

2956

1.51

13.85

1.8

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

296

1854

1.64

13.76

1.4

1.3

191.03

249.98

u/ml

0.75

284

1714

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

203

2.98

13.71

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

225

2.87

13.66

1.3

1.2

48.63

27.05

u/l

1.41

187

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

199

2.99

13.56

2.5

2.3

183.83

242.14

e6/l

1.56

175

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

714

5376

1.39

13.52

1.3

19.48

12.93

u/ml

1.13

242

1914

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

979

7749

1.33

13.44

4.1

3.3

1.17

1.15

e6/l

0.08

580

4283

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

217

2.88

13.35

1.3

1.2

78.86

83.68

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

279

2.64

13.31

1.2

1.1

—

(40768797) Stomach Pathology biopsy report

710

5365

1.38

13.13

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.64

13.04

1.1

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

204

2.92

12.99

2.3

2.5

35.08

36.64

0.23

112

(3016650) Hepatitis A virus Ab [Presence] in Serum

110

513

2.17

12.91

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

211

1229

1.75

12.87

1.4

1.5

245.25

269.45

ug/g

0.90

131

744

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

292

1854

1.61

12.86

3.9

3.4

4.05

4.41

pmol/l

6.45

255

1620

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

195

2.95

12.80

2.5

2.2

417.55

553.21

e6/l

1.13

161

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

235

2.75

12.63

1.3

1.2

140.60

102.16

u/l

1.22

197

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3742

35227

1.33

12.50

43.3

18.9

34.07

28.02

mg/l

20.38

3595

29883

(40759836) Histone Ab [Presence] in Serum by Immunoblot

248

2.69

12.47

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

101

463

2.21

12.38

1.2

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

211

2.82

12.24

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

211

2.82

12.24

1.5

1.4

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

258

2.62

12.07

1.2

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1109

9049

1.30

12.04

1.8

24526650.68

23201401.15

pmol/l

0.03

897

7379

(3042111) Morphology [Interpretation] in Bone marrow Narrative

155

840

1.87

12.01

1.7

1.5

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

8.66

11.98

2.2

1.6

58.28

60.10

0.07

(3041096) Erythrocytes [Presence] in Urine by Automated

1235

10225

1.28

11.96

5.2

3.7

0.50

0.21

estimate

0.25

505

3229

(3045142) Bone marrow Pathology biopsy report

109

523

2.11

11.93

1.4

1.3

—

(3047189) Immunofixation for 24 hour Urine

243

2.66

11.86

2.0

1.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

235

2.66

11.54

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.29

11.46

2.1

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

285

2.48

11.28

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

3.76

11.27

1.1

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

456

2.15

11.21

1.3

1.2

3.97

3.15

u/ml

0.20

157

(3009214) Lutropin [Units/volume] in Serum or Plasma

126

653

1.96

11.19

1.3

1.5

14.37

9.95

u/l

1.89

521

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

263

2.53

11.12

1.1

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

229

2.64

11.04

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

230

2.63

10.94

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

436

2.16

10.84

1.4

1.2

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

8.84

10.74

1.9

1.5

8.18

22.93

1.10

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

246

2.54

10.56

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

246

2.54

10.56

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

124

654

1.92

10.48

1.3

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.81

10.47

1.2

0.28

0.69

u/ml

—

(3008295) Osmolality of Serum or Plasma

463

2.10

10.42

1.4

1.3

269.38

276.60

mosm/kgh2o

2.11

342

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

123

653

1.91

10.20

1.5

1.2

31.54

43.26

u/ml

0.44

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

188

1133

1.69

10.20

1.4

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3279

34800

0.80

10.13

6.0

6.3

2.37

2.51

mmol/l

15.22

2909

31803

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3165

33716

0.80

10.10

5.3

5.4

1.36

1.41

mmol/l

10.24

2814

30706

(3040151) Glucose [Moles/volume] in Capillary blood

107

544

1.99

10.07

6.8

9.3

6.72

7.59

mmol/l

2.67

443

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

240

2.52

10.07

1.2

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

246

2.50

10.07

1.8

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

246

2.50

10.07

1.8

1.6

—

(40768441) Liver Pathology biopsy report

246

2.50

10.07

1.7

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

223

2.58

10.01

2.6

2.0

19.23

31.58

umol/l

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.62

9.99

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

109

3.32

9.97

1.2

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

100

502

2.01

9.77

1.5

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3200

34012

0.81

9.75

5.4

5.5

4.19

4.38

mmol/l

19.97

2863

31204

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

142

2.98

9.71

2.5

1.7

60.65

63.79

ug/l

0.08

137

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

137

3.01

9.67

2.6

2.4

0.60

0.62

mmol/l

0.94

137

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

103

525

1.98

9.65

1.5

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

147

843

1.77

9.55

1.6

1.3

36.91

40.62

u/l

0.20

129

725

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

500

2.00

9.52

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

500

2.00

9.52

1.5

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.54

9.48

1.9

1.3

—

(3011985) Renin [Units/volume] in Plasma

103

533

1.95

9.25

1.7

1.4

85.26

78.02

mu/l

0.11

473

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1914

17000

1.22

9.25

2.9

2.4

78.14

78.73

nmol/l

0.37

1708

14991

(3019230) Fractional oxyhemoglobin in Venous blood

164

980

1.70

9.22

5.6

2.4

63.50

61.05

0.73

164

975

(3017704) Immunofixation for Urine

282

2.32

9.18

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

453

2.03

9.12

1.3

1.2

4.42

5.95

u/ml

0.34

203

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

100

515

1.96

9.12

1.5

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

284

2.31

9.04

1.6

1.9

8.00

8.25

mmol/l

0.21

284

(3024522) Salmonella sp identified in Specimen by Organism specific culture

100

518

1.95

8.97

1.5

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.62

8.54

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.39

8.46

2.6

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1508

13174

1.22

8.40

2.1

1.8

19.80

19.78

nmol/l

0.02

1326

11092

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

400

2.04

8.34

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

161

2.69

8.30

1.5

1.3

—

(4195642) Thrombophilia screening test

383

2.05

8.16

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

324

2.15

8.11

2.0

1.9

4846.26

2663.61

u/l

0.27

119

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1688

14953

1.20

8.04

5.7

4.2

0.01

0.08

estimate

1.57

531

3472

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

130

2151

0.59

7.99

1.9

2.1

3.27

3.45

ratio

1.06

104

1738

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1516

0.53

7.75

1.7

1.8

3.26

3.38

mmol/l

0.38

1096

(3022493) Free Hemoglobin [Mass/volume] in Plasma

205

2.41

7.57

3.0

4.1

55.97

68.92

mg/l

1.10

142

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

255

2.25

7.56

2.9

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

209

1397

1.52

7.45

1.7

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

136

2.73

7.43

2.2

2.5

9.40

10.27

kpa

1.25

136

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

136

2.73

7.43

2.1

2.5

4.94

4.74

kpa

0.65

136

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

489

1.88

7.39

1.2

1.4

388.10

292.74

pmol/l

0.33

399

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

181

1176

1.56

7.34

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

291

2.15

7.33

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.68

7.18

1.1

1210.00

770.59

titre

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

475

1.87

7.07

1.5

62.47

63.06

0.05

296

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.00

6.91

1.3

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

427

3284

1.33

6.91

1.8

1.7

1.76

1.58

3.65

347

2778

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

387

1.95

6.90

1.2

110.43

112.00

0.15

356

(21494434) Karyotype in Bone marrow

423

1.91

6.85

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.26

6.82

1.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3199

33657

0.84

6.79

7.8

7.3

41.38

40.41

mmol/mol

6.34

2881

31031

(3013512) EKG study

1635

14606

1.19

6.78

6.0

4.1

1.00

0.78

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.01

6.61

3.4

5.9

—

753.60

—

(3003694) ABO and Rh group [Type] in Blood

1130

9784

1.21

6.61

1.4

1.3

—

(3021788) Differential panel - Synovial fluid

128

787

1.64

6.57

1.6

1.5

—

1.00

—

(40757373) Influenza virus identified in Isolate

3.18

6.55

1.9

1.3

—

(4268621) Lupus anticoagulant assay

312

2.03

6.52

2.2

2.3

—

(3052592) Norovirus Ag [Presence] in Stool

3.03

6.33

1.2

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

421

1.87

6.31

5.5

3.3

13.92

11.45

index

1.22

217

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.25

6.27

1.1

1.2

—

(3033099) Centromere Ab [Titer] in Serum

3.25

6.27

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

950

11011

0.83

6.20

3.7

3.6

—

(40768795) Lymph node Pathology biopsy report

361

1.93

6.14

1.4

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

299

2.02

6.13

1.9

1.2

92.43

98.70

pmol/l

0.43

299

(21494755) Public health laboratory ask at order entry panel

1522

0.58

6.10

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

149

970

1.55

6.06

1.3

1.2

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

411

3209

1.31

5.98

4.6

2.8

53.54

61.14

ml/min/173m2

3.96

229

1409

(42529406) Shigella sp [Presence] in Stool by Culture

150

984

1.54

5.91

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

149

979

1.54

5.83

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

484

3891

1.27

5.63

3.5

2.6

0.36

0.51

e6/l

1.27

470

3766

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.85

5.50

3.8

2.1

1.25

2.26

ratio

2.34

(3002256) Pathology report gross observation

646

5381

1.23

5.50

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

4.61

5.47

3.7

4.9

62.76

57.87

ug/min

0.07

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.47

5.44

1.2

174.58

1553.63

ng/l

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.86

5.42

1.7

2.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

205

2.16

5.40

1.4

1.3

0.38

1.81

u/ml

1.52

114

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.20

5.38

5.5

3.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.72

5.26

1.5

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

158

2.29

5.11

1.3

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

356

1.84

5.10

1.4

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.73

5.09

5.7

8.0

5.19

5.44

kpa

0.24

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

10.02

5.02

1.0

1.44

1.11

u/field

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

345

1.84

4.95

1.4

1.7

—

1428.57

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

533

1.66

4.89

1.3

212.34

228.05

miu/ml

0.08

179

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

108

2.51

4.70

3.0

2.5

27.81

388.59

ug/l

0.74

108

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3099

32373

0.87

4.61

4.6

1.28

1.27

mmol/l

0.36

2739

29116

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.81

4.54

5.9

7.6

10.07

10.33

0.22

(3013005) Retinol [Moles/volume] in Serum or Plasma

129

2.33

4.49

1.6

1.8

1.97

1.87

umol/l

0.21

118

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

116

769

1.52

4.45

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2075

19296

1.14

4.42

2.5

2.3

92.50

92.97

pmol/l

0.19

1241

10430

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

959

10832

0.86

4.40

3.3

3.5

0.81

0.83

ug/l

0.22

703

7723

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

887

0.55

4.35

1.7

5.90

4.95

mg/l

0.20

673

(3003329) Lymphocytes/Leukocytes in Synovial fluid

383

1.73

4.33

1.7

1.5

24.85

27.62

0.31

245

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

274

1.87

4.30

1.0

303.42

286.19

mg/l

0.83

244

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

560

1.60

4.30

2.4

2.1

35.57

23.43

mg/l

1.13

191

(3044889) 12 lead EKG panel

2762

26197

1.14

4.24

6.2

4.6

0.83

1443.53

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

319

1.80

4.23

1.2

92.30

93.99

0.18

300

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

199

2.02

4.21

1.3

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

395

1.71

4.17

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

180

2.06

4.14

1.5

12.03

6.00

u/l

0.62

160

(3036525) Urea [Moles/time] in 24 hour Urine

5.25

4.14

3.0

4.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

109

2.39

4.13

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

109

2.39

4.13

1.2

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

109

2.39

4.13

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

109

2.39

4.13

1.2

1.0

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2952

28151

1.14

4.08

49.4

23.6

14.75

13.85

141.16

2928

27737

(3026389) Candida sp identified in Specimen by Organism specific culture

436

1.66

4.07

1.3

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

109

732

1.50

3.97

1.2

1.1

4.01

3.47

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

417

1.66

3.94

1.2

1.3

—

nmol/l

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

4.07

3.89

3.3

2.8

1.43

1.28

mg/l

0.15

(1761482) Bacteria [#/volume] in Urine by Culture

164

1198

1.38

3.82

5.2

4.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

347

1.71

3.74

1.1

—

3.52

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.59

3.74

1.2

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1368

14915

0.88

3.66

4.6

5.0

21.94

22.40

0.51

750

8009

(1002224) Polysomnography panel

1146

0.64

3.62

1.0

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

149

1083

1.39

3.60

1.6

19626.32

15302.03

e6/l

0.36

111

740

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

240

1.84

3.60

2.2

2.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

138

992

1.40

3.56

1.6

—

(3034426) Prothrombin time (PT)

2.40

3.55

1.4

1.3

29.45

28.35

0.20

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.62

3.49

2.8

4.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

2.42

3.46

1.1

104.81

90.68

0.54

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

201

1.90

3.43

1.1

245.88

304.38

mg/l

1.33

169

(3016750) Collection duration of Urine

230

1.83

3.41

1.8

2.0

492.55

490.39

min

0.03

161

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.66

3.39

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

3.76

3.38

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

343

1.67

3.36

1.8

2.2

679.25

646.76

0.23

208

(3020191) Ethanol [Moles/volume] in Serum or Plasma

268

1.76

3.35

1.5

1.3

0.95

1.10

promille

0.31

216

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.72

3.34

4.8

7.5

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

8.58

3.26

4.8

4.9

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

142

2.05

3.25

1.2

0.56

0.55

ratio

0.04

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

116

2.16

3.21

1.4

2.0

14.58

45.84

u/l

1.32

109

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

214

1.83

3.17

1.2

1.1

35.23

44.94

mg/l

1.20

175

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

144

2.02

3.15

1.6

96.20

93.86

umol/l

0.03

(3039443) Prostate specific Ag panel - Serum or Plasma

667

0.57

3.13

1.7

1.6

—

(3002619) Bacteria identified in Specimen by Culture

2.25

3.12

1.4

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

2.54

3.12

1.5

2.3

0.16

0.30

e9/l

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

105

2.20

3.08

1.3

1.5

0.22

0.32

mmol/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

188

1.87

3.05

1.1

—

(3049717) Cytology report of Urine Cyto stain

263

2124

1.25

3.04

2.9

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.44

3.04

1.5

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.44

3.04

1.3

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3756

36604

1.14

3.04

49.2

23.4

138.50

139.63

mmol/l

92.45

3699

35849

(3045424) Erythrocytes [Presence] in Urine

249

2000

1.26

3.02

2.7

2.2

0.19

0.47

estimate

0.24

554

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

126

2.07

3.02

1.2

13.70

11.00

pmol/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

233

1.77

2.99

1.9

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

2.35

2.98

1.2

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

516

1.50

2.93

1.2

1.3

0.30

0.27

nmol/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3317

34182

0.89

2.90

5.9

5.7

6.20

6.11

mmol/l

3.14

2936

30801

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2693

28056

0.90

2.89

53.6

25.2

328.33

331.76

g/l

60.41

2667

27839

(3004716) Salmonella sp identified in Stool by Organism specific culture

169

1301

1.31

2.88

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.39

2.87

2.9

5.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

102

2.16

2.86

1.1

1.3

121.65

110.38

0.87

(40765096) Chromosome analysis panel by Banding

143

1.96

2.84

1.3

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

291

1.66

2.81

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

151

1.93

2.79

1.1

1.0

1.16

1.21

u/l

0.11

(40758292) HTLV I+II Ab panel - Serum

2.55

2.78

1.2

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.58

2.78

1.0

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3755

36650

1.13

2.75

49.6

23.6

4.05

4.01

mmol/l

15.43

3692

35846

(21491868) Cryoglobulin [Mass/volume] in Serum

138

1.96

2.74

1.7

1.2

0.24

0.33

g/l

—

(3032057) Clostridioides difficile [Presence] in Stool

104

2.12

2.74

2.3

1.8

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.71

1.5

1.3

72.88

79.37

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.01

2.70

5.2

6.7

596.00

388.20

umol/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

510

1.48

2.69

1.8

1.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

437

1.52

2.69

1.2

1.3

0.20

0.24

nmol/l

0.49

361

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.28

2.67

1.7

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

422

1.52

2.66

1.5

1.3

60838.89

121049.90

e6/l

0.78

288

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

559

0.57

2.65

1.2

1.1

0.67

0.64

ratio

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.66

2.62

1.5

1.3

62.88

79.28

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

191

1.79

2.61

1.8

1.7

37.97

39.78

g/l

0.96

191

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.13

2.54

1.6

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

855

0.66

2.50

1.5

1.7

—

(3020491) Glucose [Moles/volume] in Blood

271

1.63

2.46

1.8

1.7

7.49

6.89

mmol/l

0.72

174

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.81

2.46

1.0

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

374

1.53

2.45

1.5

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

152

1.85

2.42

1.1

77.71

375.39

ng/l

—

(3034891) Synovial lining cells/cells in Synovial fluid

190

1.74

2.37

1.5

1.4

2.75

3.74

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.64

2.36

1.4

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.64

2.36

1.4

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.12

2.36

1.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

138

1066

1.30

2.35

2.3

2.2

180.26

98.04

ug/min

0.96

614

(3020393) Adenovirus Ag [Presence] in Stool

3.03

2.35

1.0

1.1

—

(40768443) Skin Pathology biopsy report

226

1855

1.23

2.33

1.2

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

1112

10275

1.11

2.33

4.0

3.2

0.00

0.06

3.29

346

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

162

1.80

2.30

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.22

2.30

1.4

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.12

2.28

1.5

10.73

9.01

ug/l

0.96

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.62

2.27

1.5

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

522

1.42

2.25

6.3

4.5

358.18

337.86

umol/l

0.72

447

(37208534) Antinuclear antibody arbitrary concentration in serum

106

1.99

2.25

1.0

—

(40760409) HLA-A [Type] by High resolution

5.56

2.21

1.0

—

(3013862) HLA-DP [Type]

5.56

2.21

1.0

—

(40760410) HLA-B [Type] by High resolution

5.56

2.21

1.0

—

(40763590) HLA-DQ beta [Type]

5.56

2.21

1.0

—

(46236302) HLA-C [Type] by High resolution typing

5.56

2.21

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.69

2.20

1.1

1.5

37.00

47.90

umol/l

1.00

(3011397) Hemoglobin [Presence] in Urine by Test strip

1038

9585

1.11

2.19

4.8

4.0

0.00

0.53

0.80

134

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.50

2.18

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.50

2.18

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

788

7175

1.12

2.16

1.3

0.88

1.75

u/ml

6.33

175

1834

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.69

2.15

3.1

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.78

2.13

2.1

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.78

2.13

2.1

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.78

2.13

2.1

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

161

1287

1.26

2.13

1.9

1.6

0.40

0.33

mg/l

0.73

568

(3046861) Legionella sp Ag [Presence] in Urine

3.20

2.09

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.56

2.07

3.5

2.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

146

0.34

2.00

1.4

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

140

1.79

2.00

1.4

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.64

2.00

2.3

2.1

22.91

17.33

umol/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

1033

0.73

1.99

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

257

3025

0.84

1.99

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.34

1.96

12.6

9.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.03

1.95

1.3

82.24

93.75

0.47

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

113

1447

0.78

1.95

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

4.55

1.94

1.4

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.75

1.93

3.5

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

113

1.86

1.91

1.3

1.1

—

(40768800) Prostate Pathology biopsy report

100

1297

0.77

1.91

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

372

1.46

1.91

1.5

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

106

817

1.30

1.90

1.8

4.15

11.57

iu/l

0.46

297

(3021387) Prolactin [Units/volume] in Serum or Plasma

609

1.35

1.89

2.1

1.8

363.86

287.36

mu/l

1.27

565

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

157

0.38

1.88

1.2

1.6

36.95

60.79

ug/l

—

126

(3048689) Calprotectin [Mass/mass] in Stool

439

3892

1.14

1.87

2.2

2.3

215.64

161.05

ug/g

1.56

356

3066

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

115

899

1.29

1.86

1.4

1.3

523.30

618.78

mg/l

1.12

109

848

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

441

1.41

1.86

1.1

35.44

18.84

au/ml

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

107

1.87

1.86

1.2

0.33

0.30

g/l

0.97

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

129

1.79

1.85

1.1

1782.78

1616.88

miu/ml

0.27

129

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1.98

1.84

2.0

1.8

2.23

4.72

ug/l

0.74

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.53

1.83

2.3

2.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

369

1.44

1.79

1.2

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

243

2072

1.18

1.75

1.3

38.88

63.01

au/ml

1.54

145

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

767

1.30

1.74

1.5

20939.52

910.37

e6/l

0.47

602

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.50

1.74

1.9

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.67

1.72

1.3

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

760

1.30

1.71

1.4

34.96

32.20

e6/l

0.03

567

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

194

1.60

1.71

1.3

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

194

1.60

1.71

1.1

2.0

22.77

13.70

umol/l

0.37

127

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

149

1216

1.23

1.70

1.5

1.6

31.45

23.51

u/ml

0.37

223

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

195

1.59

1.68

1.3

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.18

1.67

1.9

3.6

46.71

41.76

umol/l

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.38

1.61

1.1

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.95

1.59

1.1

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.33

1.58

1.5

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.69

1.58

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

624

0.70

1.55

1.2

1.51

1.52

g/l

0.07

624

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.43

1.53

1.1

0.06

0.02

u/ml

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

100

1.80

1.52

1.2

30.00

29.77

0.01

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

218

1.52

1.48

2.3

2.1

17.11

16.64

nmol/l

0.09

201

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.44

1.47

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

204

2376

0.85

1.46

1.2

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2738

26633

1.07

1.46

4.7

4.1

15.27

15.01

pmol/l

5.02

2466

23931

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

179

1.57

1.45

1.4

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.50

1.45

1.0

1.4

—

(40768793) Breast Pathology biopsy report

674

1.28

1.43

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

794

1.25

1.38

1.4

1.3

4.27

3.85

mmol/l

1.46

736

(3020682) Albumin/Creatinine [Ratio] in Urine

1543

14750

1.07

1.37

5.0

4.2

24.74

8.94

mg/mmol

11.56

1052

9460

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.20

1.37

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.61

1.36

1.3

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

104

1.73

1.36

1.4

1.6

1983.06

482.81

nmol/24h

0.38

104

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

204

1762

1.17

1.32

1.2

106.64

131.77

u/ml

0.41

597

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

320

0.62

1.31

1.1

1.0

875.64

667.20

ng/l

0.66

202

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

184

1.52

1.31

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

259

2279

1.14

1.31

2.5

13.65

21.41

au/ml

1.48

170

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

351

1.37

1.30

1.2

1.4

343.33

242.25

titre

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

319

0.63

1.30

1.1

1.0

51.93

43.15

ng/l

0.39

204

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.36

1.29

1.0

1.1

108.00

94.12

titre

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

318

0.63

1.28

1.2

1.0

541.31

315.47

ng/l

0.69

206

(3022475) Manganese [Moles/volume] in Blood

2.78

1.28

1.2

1.4

0.19

0.16

umol/l

—

(4198724) Urine methamphetamine measurement

1.89

1.28

2.1

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.72

1.27

2.8

2.2

149.50

144.44

nmol/l

0.09

(4024509) Urine culture

170

1980

0.85

1.25

2.5

2.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

261

1.42

1.24

2.9

1.9

147.24

125.59

ng/l

0.33

261

(3043410) Blood group antigens tested for on Red Blood Cells

115

1.65

1.24

1.4

2.1

—

(3006653) Thiamine [Moles/volume] in Blood

188

1.49

1.21

1.5

1.2

147.93

137.22

nmol/l

0.48

188

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.31

1.18

1.2

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

222

1.44

1.18

5.6

2.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

623

0.75

1.16

1.4

—

(3019174) dRVVT (LA screen)

2.50

1.15

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

413

1.31

1.13

1.8

1.7

30.37

27.19

u/ml

0.20

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3717

36653

1.07

1.13

22.9

12.9

24.71

25.71

u/l

1.80

3629

35298

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

525

4855

1.09

1.12

5.0

5.3

33.36

33.16

0.14

369

3087

(3035320) C reactive protein [Mass/volume] in Body fluid

304

1.35

1.07

3.2

2.7

28.06

33.15

mg/l

0.40

230

(3034988) Calcium [Moles/volume] in Capillary blood

1.71

1.05

2.1

1.7

1.14

1.19

mmol/l

1.66

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.84

1.02

1.4

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

221

1.41

1.02

2.0

1.8

1.45

2.47

u/field

0.79

153

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

238

1.39

1.02

1.8

2.2

60.50

191.21

ug/min

0.73

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.88

1.00

2.2

2.7

0.74

0.66

ug/l

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.62

0.99

1.9

2.5

239.06

202.21

0.56

(4034850) Laboratory test

1178

0.84

0.99

18.4

12.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

751

1.20

0.94

1.1

9.54

9.24

eliau/ml

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.65

0.94

1.4

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.22

0.93

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

391

1.28

0.93

1.8

2.0

1.62

1.33

u/field

0.30

211

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.72

0.92

2.0

1.6

2.00

810.79

pmol/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

476

0.75

0.92

1.3

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3769

37252

1.06

0.91

52.4

25.6

97.38

85.60

umol/l

21.87

3711

36684

(36660697) Celiac disease serology panel - Serum

281

2553

1.11

0.91

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.79

0.87

1.5

1.2

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.00

0.87

1.0

1.3

1.36

1.55

umol/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

529

4958

1.08

0.85

14.9

8.2

—

(44806071) Cardiolipin IgM antibody measurement

1.82

0.79

1.3

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.4

—

1.03

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

327

3537

0.92

0.78

2.2

11.06

12.61

nmol/l

2.19

271

3092

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.70

0.75

1.0

1.5

—

(3011288) Drugs identified in Urine by Screen method Nominal

324

1.27

0.74

5.0

2.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

227

1.32

0.74

1.3

1.48

1.15

nmol/l

0.68

159

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

116

1.47

0.74

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.84

0.73

1.7

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

443

1.22

0.72

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

562

1.20

0.71

1.1

99.61

56.28

iu/ml

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

156

1741

0.89

0.71

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

665

1.18

0.70

1.3

1.4

29.08

29.29

iu/l

0.02

571

(3000764) Benzodiazepines [Presence] in Urine

463

1.21

0.70

4.0

1.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

310

1.26

0.69

1.1

0.92

3.78

u/ml

3.31

154

(1001926) Buprenorphine [Presence] in Urine by Screen method

364

1.24

0.69

4.4

1.9

—

(40762887) Creatinine [Moles/volume] in Blood

1.85

0.68

1.6

1.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.60

0.68

1.5

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

136

1.40

0.66

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.79

0.66

1.0

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.59

0.65

1.1

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

177

0.68

0.63

1.6

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

200

0.70

0.62

1.2

1.4

114.74

203.82

pmol/l

1.03

200

(3028300) Cannabinoids [Presence] in Urine

470

1.19

0.62

4.0

1.9

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.06

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

139

1.37

0.60

1.4

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.54

0.59

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

790

1.14

0.58

2.2

1.5

1.02

0.84

nmol/l

0.62

650

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

193

1.30

0.57

2.2

1.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.48

0.57

1.1

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.67

0.56

1.0

1.1

7.83

10.61

u/l

—

(3025130) Human papilloma virus identified in Specimen

229

1.27

0.56

1.7

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

374

1.21

0.56

1.1

0.71

1.51

u/ml

1.25

202

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.43

0.56

1.4

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1505

14683

1.04

0.56

4.2

3.5

6.71

7.37

mmol/l

8.95

1238

12196

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.62

0.55

2.8

1.4

24.28

20.66

mmol/l

—

(3027008) Opiates [Presence] in Urine

467

1.18

0.55

4.0

1.9

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.42

0.54

3.7

2.1

0.81

1.20

ug/l

0.76

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1809

18463

0.97

0.53

5.5

6.1

4.91

3.84

ug/l

0.24

1559

16562

(3027944) Amphetamines [Presence] in Urine

460

1.18

0.53

4.1

1.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

108

1.39

0.53

1.3

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.43

0.53

2.0

2.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

146

0.68

0.52

1.3

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

100

1.40

0.51

1.4

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

305

1.21

0.51

1.1

0.37

1.62

u/ml

1.55

133

(44813793) Dust mix specific IgE antibody measurement

179

1.29

0.51

1.0

—

(4146454) Self-monitoring of blood glucose

510

1.16

0.49

2.8

2.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

624

1.14

0.48

1.5

1.8

3.32

4.59

mmol/24h

3.33

533

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.52

0.48

1.9

1.5

—

(3006270) Folate [Moles/volume] in Blood

363

1.19

0.48

1.1

1.2

333.92

329.05

nmol/l

0.05

284

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.43

0.46

2.6

1.43

0.31

u/field

—

(3022689) Creatine [Moles/volume] in Urine

121

0.66

0.45

1.1

1.5

5.63

7.46

mmol/l

—

121

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.37

0.43

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

148

1.28

0.43

1.4

1.2

36.37

39.97

g/l

0.64

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

1.56

0.42

1.4

1.1

—

22.29

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.52

0.41

3.2

5.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.41

0.0

1.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.01

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

2.23

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

484

1.14

0.39

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.09

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.39

0.0

1.0

—

125.57

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

258

0.81

0.38

8.8

5.6

279.34

40.00

u/ml

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.35

0.37

1.0

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.35

0.37

1.0

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

198

1.21

0.36

1.3

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

272

1.18

0.36

1.2

1.1

0.98

1.26

u/ml

0.15

145

(3005011) Chlamydia sp Ab [Titer] in Serum

1.40

0.35

1.3

1.6

—

(3019150) Specific gravity of Urine by Refractometry

934

9124

1.03

0.34

5.6

4.4

1.02

1.18

kg/l

0.51

711

6224

(3022145) Colonoscopy Study observation

452

4360

1.04

0.34

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

133

1425

0.93

0.33

1.7

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.70

0.33

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

241

2293

1.05

0.33

5.4

3.7

1.02

ratio

0.26

226

2080

(3012516) Albumin [Mass/volume] in Urine

1464

14400

1.02

0.32

4.2

3.5

111.66

49.55

mg/l

9.42

1038

9528

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.31

0.31

2.0

2.2

—

(3016879) Cocaine [Presence] in Urine

438

1.12

0.30

4.4

2.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

344

1.13

0.29

1.0

1.1

3.51

2.50

eliau/ml

—

115

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

163

0.80

0.29

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

107

0.75

0.29

1.4

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

103

1.26

0.28

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

150

1.20

0.26

1.2

1.3

116.67

169.01

mmol/24h

3.21

150

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.73

0.24

1.5

1.6

53.27

50.36

ug/l

—

(3007461) Platelets [#/volume] in Blood

3771

37553

1.02

0.23

60.6

28.8

249.08

238.33

e9/l

13.87

3701

36606

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3374

33564

1.02

0.23

39.3

19.2

70.43

73.42

ml/min/173m2

10.88

3221

31404

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3771

37556

1.02

0.23

60.3

28.7

92.01

91.80

1.73

3717

36990

(44806420) Estimation of glomerular filtration rate

313

1.12

0.23

2.8

2.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

179

0.84

0.23

1.1

—

(3010813) Leukocytes [#/volume] in Blood

3772

37567

1.02

0.23

60.5

28.8

7.49

6.93

e9/l

20.98

3691

36464

(3035941) MCH [Entitic mass]

3771

37557

1.02

0.23

60.2

28.6

30.23

30.50

14.51

3717

36992

(3026361) Erythrocytes [#/volume] in Blood

3771

37558

1.02

0.22

60.4

28.7

4.16

4.41

e12/l

124.00

3694

36464

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3771

37559

1.02

0.22

61.6

29.3

37.74

39.75

95.70

3717

36969

(3000963) Hemoglobin [Mass/volume] in Blood

3771

37563

1.02

0.22

61.0

29.0

124.28

133.28

g/l

192.53

3723

37013

(3023410) Appearance of Cerebral spinal fluid

343

1.11

0.22

1.6

—

(3001729) Color of Synovial fluid

1.19

0.21

2.2

1.3

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

9.10

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

27.26

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.25

0.20

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.24

0.18

3.4

6.4

8.43

8.69

mmol/l

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

251

1.12

0.18

1.1

1.5

0.10

0.26

nmol/l

6.02

193

(3045414) Leukocytes [Presence] in Urine

404

3956

1.02

0.16

2.6

2.2

0.03

0.01

estimate

0.34

740

(4133840) Spirometry

1.15

0.15

1.0

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

140

1.14

0.15

1.0

—

(3024263) Appearance of Synovial fluid

223

0.90

0.14

1.8

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

118

0.85

0.14

1.2

1.6

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.82

0.13

1.3

1.2

22.50

11.89

mm/h

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

109

0.83

0.13

1.3

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

210

1.10

0.12

1.0

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3234

32442

0.99

0.12

5.9

5.2

2.20

2.03

mu/l

3.94

2922

29413

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

1.14

0.11

1.2

1.1

—

(3022621) pH of Urine by Test strip

309

3146

0.98

0.11

3.1

3.0

6.06

6.05

0.13

229

2250

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

182

1.10

0.11

1.5

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

239

0.92

0.10

1.2

1.1

7.32

2.91

u/ml

0.52

123

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

126

1296

0.97

0.10

1.7

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

252

1.07

0.09

1.6

1.5

121.85

94.90

umol/l

0.41

252

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

393

3881

1.01

0.08

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

361

1.05

0.08

1.4

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.83

0.07

4.3

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

926

1.03

0.07

4.1

3.6

31.00

30.96

mg/l

0.00

662

(3036071) Salmonella sp Ab [Titer] in Serum

1.07

0.07

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

204

0.93

0.07

1.2

1.1

2.90

0.24

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

364

1.04

0.06

1.4

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

588

0.97

0.06

2.4

1.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

150

0.93

0.04

1.1

—

17.00

—

(3006462) Nitrate [Presence] in Urine

180

0.94

0.04

4.1

4.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

109

0.92

0.04

1.1

1.4

1.16

1.17

mmol/l

—

109

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

211

1.04

0.03

1.9

356.59

353.31

mu/l

0.01

164

(3000034) Microalbumin [Mass/volume] in Urine

381

1.02

0.02

3.3

3.2

61.37

33.87

mg/l

0.47

294

(3032773) Endomysium IgG Ab [Titer] in Serum

288

0.97

0.02

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

177

0.96

0.01

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

114

1.05

0.00

1.6

1.9

0.00

0.05

estimate

0.80

114

(3025018) Bordetella pertussis Ab [Titer] in Serum

174

1.03

0.00

1.1

1.2

—

(3025577) Chromium [Mass/volume] in Blood

294

1.02

0.00

2.0

2.2

2.24

2.06

ug/l

0.10

248

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

142

0.99

0.00

1.9

2.8

28.88

29.19

umol/l

—

102

(3023511) Choriogonadotropin [Units/volume] in Urine

145

1.03

0.00

1.9

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

484

0.99

0.00

2.3

1.9

—

(4211845) Urine protein measurement

199

1.01

0.00

3.9

3.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

221

1.00

0.00

1.2

1.1

2.35

3.38

u/ml

0.22

100

(3008898) HLA-B27 [Presence]

790

1.00

-0.00

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

292.87

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.1

—

1.29

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

61.67

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.91

-0.00

1.0

1.1

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

32.80

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

0.96

-0.00

3.0

2.2

9.37

8.94

mg/l

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

1.00

-0.00

2.2

1.6

8.10

9.29

mmol/l

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

5.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_PLEUROTH and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_PLEUROTH	5.148 [4.33, 6.12]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 4491 out of 7479 females with J10_PLEUROTH died.

Males

Parameter	HR [95% CI]	p-value
J10_PLEUROTH	3.722 [3.21, 4.31]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.017

During the follow-up period (1.1.1998 — 31.12.2019), 6334 out of 11188 males with J10_PLEUROTH died.

Mortality risk

Mortality risk for people of age

years, who have J10_PLEUROTH.

N-year risk	Females	Males
1	0.428%	0.56%
5	2.282%	4.013%
10	5.981%	9.919%
15	11.678%	18.879%
20	19.82%	31.195%

Relationships between endpoints

↥

Index endpoint: J10_PLEUROTH – Other pleural conditions

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other pleural conditions

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints